US20110014611A1 - Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis - Google Patents
Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis Download PDFInfo
- Publication number
- US20110014611A1 US20110014611A1 US12/734,227 US73422708A US2011014611A1 US 20110014611 A1 US20110014611 A1 US 20110014611A1 US 73422708 A US73422708 A US 73422708A US 2011014611 A1 US2011014611 A1 US 2011014611A1
- Authority
- US
- United States
- Prior art keywords
- nucleic acid
- dntp
- dna
- fluorophore
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *COP(O)(O)OC[C@]([C@@](C1)O)O[C@]1N(C=C(C(N1)=O)C#CCOC(c2c(C[N-])cccc2)=O)C1=O Chemical compound *COP(O)(O)OC[C@]([C@@](C1)O)O[C@]1N(C=C(C(N1)=O)C#CCOC(c2c(C[N-])cccc2)=O)C1=O 0.000 description 24
- JLPZSIOCNSDYAV-UHFFFAOYSA-N CCOC1=CC(CN=[N+]=[N-])=C(C(=O)OC)C=C1 Chemical compound CCOC1=CC(CN=[N+]=[N-])=C(C(=O)OC)C=C1 JLPZSIOCNSDYAV-UHFFFAOYSA-N 0.000 description 14
- RSZHNHOGMUHTQN-UHFFFAOYSA-N CCCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NC)=CC=C1 Chemical compound CCCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NC)=CC=C1 RSZHNHOGMUHTQN-UHFFFAOYSA-N 0.000 description 10
- IODKOTRLZXZLAC-UHFFFAOYSA-N CNCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NC)=CC=C1 Chemical compound CNCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NC)=CC=C1 IODKOTRLZXZLAC-UHFFFAOYSA-N 0.000 description 5
- BHCPSDYTDAASMD-IVRBFZATSA-K C.C=C(CCCOC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1)CCC1=[N+]2C(C=C1)CC1=C(C)C=C(C)C1[B-]2(F)F Chemical compound C.C=C(CCCOC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1)CCC1=[N+]2C(C=C1)CC1=C(C)C=C(C)C1[B-]2(F)F BHCPSDYTDAASMD-IVRBFZATSA-K 0.000 description 4
- VMZROGKEWJIVLZ-DTFAEPQDSA-D C.CC/C=C1/C=C2OC3=C(C=C(C)C(CCC)=C3)C(C3=CC(C(=O)CCCOC4=CC(CN=[N+]=[N-])=C(OCC(=O)OCC#CC5=CN([C@H]6CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O6)C(=O)NC5=O)C=C4)=CC=C3C(=O)[O-])=C2C=C1C.[N-]=[N+]=NCOC1C[C@H](N2C=C(C#CCOC(=O)COC3=C(CN=[N+]=[N-])C=C(OCCCC(=O)C4=CC=C(C(=O)[O-])C(C5=C6C=C7CCC[N+]8=C7C(=C6OC6=C5C=C5CCCN7CCCC6=C57)CCC8)=C4)C=C3)C3=C2N=CN=C3N)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O.[N-]=[N+]=NCOC1C[C@H](N2C=C(C#CCOC(=O)COC3=C(CN=[N+]=[N-])C=C(OCCCC(=O)CCCC(=O)COC4=CC=C(/C=C/C5=[N+]6C(=CC7=CC=C(C8=CC=CS8)N7[B-]6(F)F)C=C5)C=C4)C=C3)C3=C2N=C(N)NC3=O)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O Chemical compound C.CC/C=C1/C=C2OC3=C(C=C(C)C(CCC)=C3)C(C3=CC(C(=O)CCCOC4=CC(CN=[N+]=[N-])=C(OCC(=O)OCC#CC5=CN([C@H]6CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O6)C(=O)NC5=O)C=C4)=CC=C3C(=O)[O-])=C2C=C1C.[N-]=[N+]=NCOC1C[C@H](N2C=C(C#CCOC(=O)COC3=C(CN=[N+]=[N-])C=C(OCCCC(=O)C4=CC=C(C(=O)[O-])C(C5=C6C=C7CCC[N+]8=C7C(=C6OC6=C5C=C5CCCN7CCCC6=C57)CCC8)=C4)C=C3)C3=C2N=CN=C3N)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O.[N-]=[N+]=NCOC1C[C@H](N2C=C(C#CCOC(=O)COC3=C(CN=[N+]=[N-])C=C(OCCCC(=O)CCCC(=O)COC4=CC=C(/C=C/C5=[N+]6C(=CC7=CC=C(C8=CC=CS8)N7[B-]6(F)F)C=C5)C=C4)C=C3)C3=C2N=C(N)NC3=O)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O VMZROGKEWJIVLZ-DTFAEPQDSA-D 0.000 description 4
- GJGDSCZCAJTZMJ-UHFFFAOYSA-N CCCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NC)=CC=C1.CCOC1=CC(CN=[N+]=[N-])=C(C(=O)OC)C=C1 Chemical compound CCCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NC)=CC=C1.CCOC1=CC(CN=[N+]=[N-])=C(C(=O)OC)C=C1 GJGDSCZCAJTZMJ-UHFFFAOYSA-N 0.000 description 4
- SDJPDEPUKLUKQP-CAQWOJDYSA-J F.O=P([O-])([O-])OP(=O)([O-])OP(=O)([O-])OC[C@@H]1CC[C@H](C2CC[C@H]2C2CCC2)O1 Chemical compound F.O=P([O-])([O-])OP(=O)([O-])OP(=O)([O-])OC[C@@H]1CC[C@H](C2CC[C@H]2C2CCC2)O1 SDJPDEPUKLUKQP-CAQWOJDYSA-J 0.000 description 4
- NVSJIBNFDDWKHT-BBPRZFOJSA-B C.C.C.C.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(N)=NC=N3)C=C1 Chemical compound C.C.C.C.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(N)=NC=N3)C=C1 NVSJIBNFDDWKHT-BBPRZFOJSA-B 0.000 description 2
- QMCGIKDWRXFADU-HITVIYLASA-B C.C.C.CCCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CNC3([C@H]4CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O4)=C2C(=O)NC(N)=N3)=CC=C1.CCCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2=N)=CC=C1.[CH2-]P(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@@H]1CC[C@H](C23=C(C(C#CCNC(=O)COCCOC(COC4=CC=CC(C(=O)NCCCC)=C4)N=[N+]=[N-])=CN2)C(N)=NC=N3)O1.[CH2-]P(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@@H]1CC[C@H](N2C=C(CNC(=O)COCCOC(COC3=CC=CC(C(=O)NCCCC)=C3)N=[N+]=[N-])C(=O)NC2=O)O1 Chemical compound C.C.C.CCCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CNC3([C@H]4CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O4)=C2C(=O)NC(N)=N3)=CC=C1.CCCCNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2=N)=CC=C1.[CH2-]P(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@@H]1CC[C@H](C23=C(C(C#CCNC(=O)COCCOC(COC4=CC=CC(C(=O)NCCCC)=C4)N=[N+]=[N-])=CN2)C(N)=NC=N3)O1.[CH2-]P(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@@H]1CC[C@H](N2C=C(CNC(=O)COCCOC(COC3=CC=CC(C(=O)NCCCC)=C3)N=[N+]=[N-])C(=O)NC2=O)O1 QMCGIKDWRXFADU-HITVIYLASA-B 0.000 description 2
- CXSOATIPXOWQBU-SJURGUEASA-J C.CC1=CC(C)=C2C=C3C=CC(CCC(=O)CCCNC(=O)C4=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC5=CN([C@H]6CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O6)C(=O)N=C5N)=CC=C4)=[N+]3[B-](F)(F)N12 Chemical compound C.CC1=CC(C)=C2C=C3C=CC(CCC(=O)CCCNC(=O)C4=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC5=CN([C@H]6CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O6)C(=O)N=C5N)=CC=C4)=[N+]3[B-](F)(F)N12 CXSOATIPXOWQBU-SJURGUEASA-J 0.000 description 2
- AEKNZVBNKDAKJB-JGCMANKXSA-N C.CC1=CN([C@H]2CC(OCN=[N+]=[N-])[C@@H](COP3([O-])=OOP4(=OOP(=O)(O)O4)O3)O2)C(=O)NC1=O.CC1=CN([C@H]2CC(OCN=[N+]=[N-])[C@@H](COP3([O-])=OOP4(=OOP(=O)(O)O4)O3)O2)C(=O)NC1=O.[N-]=[N+]=NCOC1C[C@H](N2C=NC3=C2N=C(N)NC3=O)O[C@@H]1COP1([O-])=OOP2(=OOP(=O)(O)O2)O1.[N-]=[N+]=NCOC1C[C@H](N2C=NC3=C2N=CN=C3N)O[C@@H]1COP1([O-])=OOP2(=OOP(=O)(O)O2)O1 Chemical compound C.CC1=CN([C@H]2CC(OCN=[N+]=[N-])[C@@H](COP3([O-])=OOP4(=OOP(=O)(O)O4)O3)O2)C(=O)NC1=O.CC1=CN([C@H]2CC(OCN=[N+]=[N-])[C@@H](COP3([O-])=OOP4(=OOP(=O)(O)O4)O3)O2)C(=O)NC1=O.[N-]=[N+]=NCOC1C[C@H](N2C=NC3=C2N=C(N)NC3=O)O[C@@H]1COP1([O-])=OOP2(=OOP(=O)(O)O2)O1.[N-]=[N+]=NCOC1C[C@H](N2C=NC3=C2N=CN=C3N)O[C@@H]1COP1([O-])=OOP2(=OOP(=O)(O)O2)O1 AEKNZVBNKDAKJB-JGCMANKXSA-N 0.000 description 2
- PWBQPXJGWQXNSE-RWBYNWAKSA-J CC1C[C@H](C2CCC2)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-] Chemical compound CC1C[C@H](C2CCC2)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-] PWBQPXJGWQXNSE-RWBYNWAKSA-J 0.000 description 2
- CFZGVMJVKJWNME-KGYDVKLMSA-J CC1C[C@H](C2CC[C@H]2C2CCC2)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-].F Chemical compound CC1C[C@H](C2CC[C@H]2C2CCC2)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-].F CFZGVMJVKJWNME-KGYDVKLMSA-J 0.000 description 2
- RFQQXYNVNFKWJR-GKIXQPISSA-B C.C.C.C.C.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(N)=NC=N3)C=C1 Chemical compound C.C.C.C.C.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(N)=NC=N3)C=C1 RFQQXYNVNFKWJR-GKIXQPISSA-B 0.000 description 1
- IJFGKUKSMYYGTL-PKWOCHPVSA-B C.C.C.C/C=C/C1=[N+](\CC)C2=C(C=C(C)C=C2)C1(C)C.C/C=C/C=C1/N(CCCC(=O)CCCNC(=O)C2=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC3=CN([C@H]4CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O4)C4=C3C(=O)NC(N)=N4)=CC=C2)C2=CC=C(C)C=C2C1(C)C.CC/C=C1/C=C2OC3=C(C=C(C)C(CCC)=C3)C(C3=CC(C(=O)CCCNC(=O)C4=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC5=CN([C@H]6CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O6)C(=O)NC5=O)=CC=C4)=CC=C3C(=O)[O-])=C2C=C1C.[N-]=[N+]=NC(COC1=CC=CC(C(=O)NCCCC(=O)C2=CC=C(C(=O)[O-])C(C3=C4C=C5CCC[N+]6=C5C(=C4OC4=C3C=C3CCCN5CCCC4=C35)CCC6)=C2)=C1)OCCOCC(=O)NCC#CC1=CN([C@H]2CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2)C2=C1C(N)=NC=N2 Chemical compound C.C.C.C/C=C/C1=[N+](\CC)C2=C(C=C(C)C=C2)C1(C)C.C/C=C/C=C1/N(CCCC(=O)CCCNC(=O)C2=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC3=CN([C@H]4CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O4)C4=C3C(=O)NC(N)=N4)=CC=C2)C2=CC=C(C)C=C2C1(C)C.CC/C=C1/C=C2OC3=C(C=C(C)C(CCC)=C3)C(C3=CC(C(=O)CCCNC(=O)C4=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC5=CN([C@H]6CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O6)C(=O)NC5=O)=CC=C4)=CC=C3C(=O)[O-])=C2C=C1C.[N-]=[N+]=NC(COC1=CC=CC(C(=O)NCCCC(=O)C2=CC=C(C(=O)[O-])C(C3=C4C=C5CCC[N+]6=C5C(=C4OC4=C3C=C3CCCN5CCCC4=C35)CCC6)=C2)=C1)OCCOCC(=O)NCC#CC1=CN([C@H]2CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2)C2=C1C(N)=NC=N2 IJFGKUKSMYYGTL-PKWOCHPVSA-B 0.000 description 1
- VJHJCHVQTMCNLN-PKWOCHPVSA-A C.C.C.C/C=C/C1=[N+](\CC)C2=C(C=C(C)C=C2)C1(C)C.C/C=C/C=C1/N(CCCC(=O)CCCNC(=O)C2=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC3=CN([C@H]4CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O4)C4=C3C(=O)NC(N)=N4)=CC=C2)C2=CC=C(C)C=C2C1(C)C.CC/C=C1/C=C2OC3=C(C=C(C)C(CCC)=C3)C(C3=CC(C(=O)CCCNC(=O)C4=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC5=CN([C@H]6CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O6)C(=O)NC5=O)=CC=C4)=CC=C3C(=O)[O-])=C2C=C1C.[N-]=[N+]=NC(COC1=CC=CC(C(=O)NCCCC(=O)C2=CC=C(C(=O)[O-])C(C3=C4C=C5CCCN6(#[O+])=C5C(=C4OC4=C3C=C3CCCN5CCCC4=C35)CCC6)=C2)=C1)OCCOCC(=O)NCC#CC1=CN([C@H]2CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2)C2=C1C(N)=NC=N2 Chemical compound C.C.C.C/C=C/C1=[N+](\CC)C2=C(C=C(C)C=C2)C1(C)C.C/C=C/C=C1/N(CCCC(=O)CCCNC(=O)C2=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC3=CN([C@H]4CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O4)C4=C3C(=O)NC(N)=N4)=CC=C2)C2=CC=C(C)C=C2C1(C)C.CC/C=C1/C=C2OC3=C(C=C(C)C(CCC)=C3)C(C3=CC(C(=O)CCCNC(=O)C4=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC5=CN([C@H]6CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O6)C(=O)NC5=O)=CC=C4)=CC=C3C(=O)[O-])=C2C=C1C.[N-]=[N+]=NC(COC1=CC=CC(C(=O)NCCCC(=O)C2=CC=C(C(=O)[O-])C(C3=C4C=C5CCCN6(#[O+])=C5C(=C4OC4=C3C=C3CCCN5CCCC4=C35)CCC6)=C2)=C1)OCCOCC(=O)NCC#CC1=CN([C@H]2CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2)C2=C1C(N)=NC=N2 VJHJCHVQTMCNLN-PKWOCHPVSA-A 0.000 description 1
- CPKHSICXKYJZSC-GYXNOTPPSA-E C.C.C.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)=CC=C1.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)=CC=C1.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(N)=NC=N3)=CC=C1 Chemical compound C.C.C.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)=CC=C1.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)=CC=C1.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(N)=NC=N3)=CC=C1 CPKHSICXKYJZSC-GYXNOTPPSA-E 0.000 description 1
- NFYGXLDUUZEHEY-HTRVSXAASA-C C.C.C.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)=CC=C1.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O3)C(=O)NC2=O)=CC=C1.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O3)C3=C2C(N)=NC=N3)=CC=C1 Chemical compound C.C.C.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)=CC=C1.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O3)C(=O)NC2=O)=CC=C1.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O3)C3=C2C(N)=NC=N3)=CC=C1 NFYGXLDUUZEHEY-HTRVSXAASA-C 0.000 description 1
- USLSNUKOVPCIEL-RPAPPHJISA-A C.C.C/C=C/C1=[N+](\CC)C2=C(C=C(C)C=C2)C1(C)C.C/C=C/C=C1/N(CCCC(=O)CCCNC(=O)C2=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC3=CN([C@H]4CC(OCC)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O4)C4=C3C(N)NC(N)=N4)=CC=C2)C2=CC=C(C)C=C2C1(C)C.CC/C=C1/C=C2OC3=C(C=C(C)C(CCC)=C3)C(C3=CC(C(=O)CCCNC(=O)C4=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC5=CN([C@H]6CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O6)C(=O)NC5=O)=CC=C4)=CC=C3C(=O)[O-])=C2C=C1C.CCOC1C[C@H](N2C=C(C#CCNC(=O)COCCOC(COC3=CC=CC(C(=O)NCCCC(=O)C4=CC=C(C(=O)[O-])C(C5=C6C=C7CCCN8(#[O+])=C7C(=C6OC6=C5C=C5CCCN7CCCC6=C57)CCC8)=C4)=C3)N=[N+]=[N-])C3=C2N=CN=C3N)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-] Chemical compound C.C.C/C=C/C1=[N+](\CC)C2=C(C=C(C)C=C2)C1(C)C.C/C=C/C=C1/N(CCCC(=O)CCCNC(=O)C2=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC3=CN([C@H]4CC(OCC)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O4)C4=C3C(N)NC(N)=N4)=CC=C2)C2=CC=C(C)C=C2C1(C)C.CC/C=C1/C=C2OC3=C(C=C(C)C(CCC)=C3)C(C3=CC(C(=O)CCCNC(=O)C4=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC5=CN([C@H]6CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O6)C(=O)NC5=O)=CC=C4)=CC=C3C(=O)[O-])=C2C=C1C.CCOC1C[C@H](N2C=C(C#CCNC(=O)COCCOC(COC3=CC=CC(C(=O)NCCCC(=O)C4=CC=C(C(=O)[O-])C(C5=C6C=C7CCCN8(#[O+])=C7C(=C6OC6=C5C=C5CCCN7CCCC6=C57)CCC8)=C4)=C3)N=[N+]=[N-])C3=C2N=CN=C3N)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-] USLSNUKOVPCIEL-RPAPPHJISA-A 0.000 description 1
- WGKKWTHYBOORRN-NZFKGQRVSA-N C.C.CC1=CN([C@H]2CC(OCN=[N+]=[N-])[C@@H](COP3([O-])=OOP4(=OOP(=O)(O)O4)O3)O2)C(=O)NC1=O.CC1=CN([C@H]2CC(OCN=[N+]=[N-])[C@@H](COP3([O-])=OOP4(=OOP(=O)(O)O4)O3)O2)C(=O)NC1=O.[N-]=[N+]=NCOC1C[C@H](N2/C=N\C3=C2N=C(N)NC3=O)O[C@@H]1COP1([O-])=OOP2(=OOP(=O)(O)O2)O1.[N-]=[N+]=NCOC1C[C@H](N2/C=N\C3=C2N=CN=C3N)O[C@@H]1COP1([O-])=OOP2(=OOP(=O)(O)O2)O1 Chemical compound C.C.CC1=CN([C@H]2CC(OCN=[N+]=[N-])[C@@H](COP3([O-])=OOP4(=OOP(=O)(O)O4)O3)O2)C(=O)NC1=O.CC1=CN([C@H]2CC(OCN=[N+]=[N-])[C@@H](COP3([O-])=OOP4(=OOP(=O)(O)O4)O3)O2)C(=O)NC1=O.[N-]=[N+]=NCOC1C[C@H](N2/C=N\C3=C2N=C(N)NC3=O)O[C@@H]1COP1([O-])=OOP2(=OOP(=O)(O)O2)O1.[N-]=[N+]=NCOC1C[C@H](N2/C=N\C3=C2N=CN=C3N)O[C@@H]1COP1([O-])=OOP2(=OOP(=O)(O)O2)O1 WGKKWTHYBOORRN-NZFKGQRVSA-N 0.000 description 1
- SJNIISFCJTYTEJ-WRZIZJBKSA-J C.CCOC1C[C@H](N2C=C(C#CCNC(=O)COCCOC(COC3=CC=CC(C(=O)NCCCC(=O)CCC4=[N+]5C(=CC6=C(C)C=C(C)N6[B-]5(F)F)C=C4)=C3)N=[N+]=[N-])C(N)=NC2=O)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-] Chemical compound C.CCOC1C[C@H](N2C=C(C#CCNC(=O)COCCOC(COC3=CC=CC(C(=O)NCCCC(=O)CCC4=[N+]5C(=CC6=C(C)C=C(C)N6[B-]5(F)F)C=C4)=C3)N=[N+]=[N-])C(N)=NC2=O)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-] SJNIISFCJTYTEJ-WRZIZJBKSA-J 0.000 description 1
- MDTABIZUSAQZJX-QWSXSRHCSA-K C.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2=O)=CC=C1 Chemical compound C.CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2=O)=CC=C1 MDTABIZUSAQZJX-QWSXSRHCSA-K 0.000 description 1
- GDXJXYWPOTUADF-GLCCCQKASA-F C.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(C)(=O)OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](CO[PH](=O)O[PH](=O)O[PH](=O)O)O3)C3=C2C(N)=NC=N3)C=C1 Chemical compound C.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(C)(=O)OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](CO[PH](=O)O[PH](=O)O[PH](=O)O)O3)C3=C2C(N)=NC=N3)C=C1 GDXJXYWPOTUADF-GLCCCQKASA-F 0.000 description 1
- KZPORJJBBQIGCQ-XLSWHLDHSA-K CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2=O)=CC=C1 Chemical compound CNC(=O)C1=CC(OCC(N=[N+]=[N-])OCCOCC(=O)NCC#CC2=CN([C@H]3CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2=O)=CC=C1 KZPORJJBBQIGCQ-XLSWHLDHSA-K 0.000 description 1
- IJURKGPDWVAWKQ-BREJEQATSA-B COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(N)=NC=N3)C=C1 Chemical compound COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)N=C2N)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C(=O)NC2=O)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(=O)NC(N)=N3)C=C1.COC1=CC(CN=[N+]=[N-])=C(C(=O)OCC#CC2=CN([C@H]3CC(OCN=[N+]=[N-])[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)C3=C2C(N)=NC=N3)C=C1 IJURKGPDWVAWKQ-BREJEQATSA-B 0.000 description 1
- JMGKGRQRUFMLTG-UHFFFAOYSA-M NCc(cccc1)c1C(OCC#CC(C(N1)=O)=CN(C(C2)OC(COP([O-])=O)C2O)C1=O)=O Chemical compound NCc(cccc1)c1C(OCC#CC(C(N1)=O)=CN(C(C2)OC(COP([O-])=O)C2O)C1=O)=O JMGKGRQRUFMLTG-UHFFFAOYSA-M 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/30—Oligonucleotides characterised by their secondary structure
- C12Q2525/301—Hairpin oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/157—A reaction step characterised by the number of molecules incorporated or released
Definitions
- a composition having a first, second and third portion wherein the second portion has the following structure:
- ⁇ represents a point of attachment to the first portion and ⁇ represents a point of attachment to the third portion.
- a method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising:
- a method for determining the identity of each of a series of consecutive nucleotide residues in a self-priming nucleic acid comprising:
- a kit for use in sequencing a nucleic acid comprising:
- An array comprising a nucleic acid attached to a solid surface, wherein the nucleic acid comprises an azidomethyl group attached to a 3′ atom thereof and a molecule having the structure:
- ⁇ represents a point of attachment to a 3′ base of the nucleic acid and ⁇ represents a point of attachment to a detectable marker.
- An array comprising a self-priming nucleic acid attached to a solid surface, wherein the nucleic acid comprises an azidomethyl group attached to a 3′ atom thereof and a molecule having the structure:
- ⁇ represents a point of attachment to a 3′ base of the nucleic acid and ⁇ represents a point of attachment to a detectable marker.
- a method for increasing a read length of DNA sequencing by synthesis comprising (a) providing deoxynucleotide triphosphate analogues wherein the deoxynucleotide triphosphate analogues differ from deoxynucleotide triphosphates by having a methylazido group attached to a 3′ atom thereof and by having a detectable marker attached to a 1 nitrogen or a 9 nitrogen of a base thereof through a linker comprising the structure
- a method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising:
- a method for determining the identity of each of a series of consecutive nucleotide residues in a self-priming nucleic acid comprising:
- a method for determining the identity of each of a series of consecutive nucleotide residues in a plurality of nucleic acids comprising, the same series of consecutive nucleotides comprising:
- a method for determining the identity of consecutive nucleotide residues in a self-priming nucleic acid comprising:
- a kit for use in sequencing a nucleic acid comprising:
- An array comprising a nucleic acid attached to a solid surface, wherein the nucleic acid comprises an azidomethyl group attached to a 3′ atom thereof and a molecule having the structure:
- An array comprising a self-priming nucleic acid attached to a solid surface, wherein the nucleic acid comprises an azidomethyl group attached to a 3′ atom thereof and a molecule having the structure:
- a method for increasing a read length of DNA sequencing by synthesis coupled with Sanger dideoxynucleotide terminating reaction (a) providing deoxynucleotide triphosphate analogues wherein the deoxynucleotide triphosphate analogues differ from deoxynucleotide triphosphates by having a methylazido group attached to a 3′ atom thereof and providing dideoxynucleotide triphosphate analogues wherein the dideoxynucleotide triphosphate analogues differ from dideoxynucleotide triphosphates by having a detectable marker attached to a 1 nitrogen or a 9 nitrogen of a base thereof through a linker comprising the structure
- FIG. 1 Staudinger reduction with TCEP.
- FIG. 2 3′-O-Azido-dNTPs-Azido-Dye.
- FIG. 3 Staudinger Reduction of the Azido Linker.
- FIG. 4 3′-O-Azido-dNTP-PC-Dye.
- FIG. 5 The hybrid DNA sequencing approach between the Sanger dideoxy chain-terminating reaction and sequencing by synthesis.
- four nucleotides (3′-O—R 1 -dNTPs) modified as reversible terminators by capping the 3′-OH with a small reversible moiety R1 so that they are still recognized by DNA polymerase as substrates, are used in combination with a small percentage of four cleavable fluorescent dideoxynucleotides (ddNTP-R 2 -fluorophores) to perform SBS.
- DNA sequences are determined by the unique fluorescence emission of each fluorophore on the DNA products terminated by ddNTPs.
- the polymerase reaction reinitiates to continue the sequence determination.
- FIG. 6 3′-O-Azido-dNTPs.
- FIG. 7 Solution Incorporation and reduction of 3′-O-Azido-dNTPs: polymerase extension and TCEP reduction scheme.
- FIG. 8 MALDI-TOF MS spectra of incorporation products (left column), and MALDI-TOF MS spectra of reduction products (right column).
- FIG. 9 Solution incorporation and reduction scheme of 3′-O-Azido-dNTPs-Azido-Dye.
- FIG. 10 MALDI-TOF MS spectra results for incorporation shown in FIG. 9 .
- FIG. 11 SBS scheme for 3′-O-Azido-dNTPs-Azido-Dye.
- FIG. 12 Results for incorporation shown in FIG. 11 .
- FIG. 13 Mechanisms to cleave the 3′-O-azidomethyl group and the azidolinker-fluorophore from the DNA extension products.
- FIG. 15 Synthesis of ddCTP-N 3 -Bodipy-FL-510
- FIG. 16 Synthesis of ddUTP-N 3 -R6G
- FIG. 17 Synthesis of ddATP-N 3 -ROX
- FIG. 18 Synthesis of ddGTP-N 3 -Cy5
- FIG. 19 A detailed scheme (left half of fig.) of polymerase reaction using all four 3′-O—N 3 -dNTPs to extend with an “3′-O—N 3 -dATP”, “3′-O—N 3 -dCTP”, “3′-O—N 3 -dGTP” and “3′-O—N 3 -dTTP” and the subsequent cleavage reaction to cleave off the azidomethyl moiety capping the 3′-OH of the DNA extension product.
- MALDI-TOF MS spectra verifying base specific incorporation of: (A) 3′-O—N 3 -dCTP (peak at 8,310 m/z), (B) the corresponding cleavage product (8,255 m/z); (C) 3′-O—N 3 -dGTP (peak at 8,639 m/z), (D) the corresponding cleavage product (8,584 m/z); (E) 3′-O—N 3 -dATP (peak at 8,952 m/z), (F) the corresponding cleavage product (8,897 m/z); (G) 3′-O—N 3 -dTTP (peak at 9,256 m/z) and (H) the corresponding cleavage product (9,201 m/z).
- the azidomethyl moiety capping the 3′-OH group of the DNA extension products is completely removed by TCEP aqueous solution to continue the polymerase reaction.
- FIG. 20 A detailed scheme (top half of fig.) of polymerase reaction using all four ddATP-N 3 -fluorophores to extend with an “ddA”, “ddC”, “ddG” and “ddU” and the subsequent cleavage reaction to cleave off the fluorophore from the DNA extension product.
- FIG. 21 (A) Reaction scheme of Sanger/sequencing by synthesis hybrid sequencing on a chip using combination of cleavable fluorescent dideoxynucleotides and 3′-O—N 3 -modified nucleotides.
- FIG. 22 A plot (four-color sequencing data) of raw fluorescence emission intensity obtained by using 3′-O—N3-dNTPs and ddNTP-N3-fluorophores at the four designated emission wavelengths of the four cleavable fluorescent dideoxynucleotides.
- FIG. 23 “Walking” Strategy 1
- FIG. 24 Structures of the nucleotide reversible terminators
- FIG. 25 Structures of cleavable fluorescent dideoxynucleotide terminators
- FIG. 26 Hybrid SBS scheme
- FIG. 27 Template “Walking” Method 1
- FIG. 28 Template “Walking” Method 2
- FIG. 29 Template “Walking” Method 3
- FIG. 30 Template “Walking” Method 4
- FIG. 31 Template “Walking” Method 5
- FIG. 32 Structures of the nucleotide reversible terminators, 3′-O—N 3 -dATP, 3′-O—N 3 -dCTP, 3′-O—N 3 -dGTP, 3′-O—N 3 -dTTP
- FIG. 34 (A) Staudinger reaction with TCEP to regenerate the 3′-OH group of the DNA extension product. (B) Staudinger reaction with TCEP to cleave the N 3 -fluorophore from the dideoxynucleotide.
- FIG. 35 Four-color DNA sequencing by the hybrid SBS approach
- FIG. 36 Four-color DNA sequencing by the hybrid SBS after template “walking”
- FIG. 37 General Scheme for SBS with C—F-NRTs
- FIG. 38 Structure of 3′-O—N 3 -dNTPs-N 3 -fluorophore
- FIG. 39 Four-color DNA SBS with 3′-O—N 3 -dNTPs-N 3 -fluorophore.
- FIG. 40 Template “Walking” Method 1 for SBS with C—F-NRTs
- FIG. 41 Template “Walking” Method 2 for SBS with C—F-NRTs
- FIG. 42 Template “Walking” Method 3 for SBS with C—F-NRTs
- FIG. 43 Template “Walking” Method 4 for SBS with C—F-NRTs
- FIG. 44 Template “Walking” Method 5 for SBS with C—F-NRTs
- FIG. 45 “Walking” Strategy 2
- FIG. 46 “Walking” Strategy 3
- Nucleic acid shall mean any nucleic acid molecule, including, without limitation, DNA, RNA and hybrids thereof.
- the nucleic acid bases that form nucleic acid molecules can be the bases A, C, G, T and U, as well as derivatives thereof. Derivatives of these bases are well known in the art, and are exemplified in PCR Systems, Reagents and Consumables (Perkin Elmer Catalogue 1996-1997, Roche Molecular Systems, Inc., Branchburg, N.J., USA).
- Type of nucleotide refers to A, G, C, T or U.
- Type of base refers to adenine, guanine, cytosine, uracil or thymine.
- Mass tag shall mean a molecular entity of a predetermined size which is capable of being attached by a cleavable bond to another entity.
- Solid substrate shall mean any suitable medium present in the solid phase to which a nucleic acid or an agent may be affixed.
- Non-limiting examples include chips, beads and columns.
- Hybridize shall mean the annealing of one single-stranded nucleic acid to another nucleic acid based on sequence complementarity.
- the propensity for hybridization between nucleic acids depends on the temperature and ionic strength of their milieu, the length of the nucleic acids and the degree of complementarity. The effect of these parameters on hybridization is well known in the art (see Sambrook J, Fritsch E F, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York.)
- a composition having a first, second and third portion wherein the second portion has the following structure:
- ⁇ represents a point of attachment to the first portion and ⁇ represents a point of attachment to the third portion.
- ⁇ may be directly linked to the first portion, e.g. comprising a base, or bonded to the, for example base via, e.g. an alkynylene.
- ⁇ may be directly linked to the third portion, e.g. a detectable marker, or bonded to the third portion, for example via another group.
- the first portion is a deoxynucleotide or a dideoxynucleotide and the third portion is a detectable marker.
- the detectable marker is a fluorescent dye.
- the deoxynucleotide or dideoxynucleotide comprises a methylazido group attached to a 3′ atom thereof.
- the dye in each structure is a fluorescent dye.
- a method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising:
- a method for determining the identity of each of a series of consecutive nucleotide residues in a self-priming nucleic acid comprising:
- steps b) and c) can be performed simultaneously, or in the order step b) then step c) or in the order step c) then step b).
- the nucleic acid is DNA and the nucleic acid polymerase is a 9°N thermopolymerase.
- the cleavable chemical group is a methylazido group.
- the four dNTP analogues have the following structures:
- nucleic acid is immobilized on a solid surface.
- solid surface is a chip or a bead.
- a kit for use in sequencing a nucleic acid comprising:
- An array comprising a nucleic acid attached to a solid surface, wherein the nucleic acid comprises an azidomethyl group attached to a 3′ atom thereof and a molecule having the structure:
- ⁇ represents a point of attachment to a 3′ base of the nucleic acid and ⁇ represents a point of attachment to a detectable marker.
- An array comprising a self-priming nucleic acid attached to a solid surface, wherein the nucleic acid comprises an azidomethyl group attached to a 3′ atom thereof and a molecule having the structure:
- ⁇ represents a point of attachment to a 3′ base of the nucleic acid and ⁇ represents a point of attachment to a detectable marker.
- the detectable marker is a fluorophore.
- a method for increasing a read length of DNA sequencing by synthesis comprising (a) providing deoxynucleotide triphosphate analogues wherein the deoxynucleotide triphosphate analogues differ from deoxynucleotide triphosphates by having a methylazido group attached to a 3′ atom thereof and by having a detectable marker attached to a 1 nitrogen or a 9 nitrogen of a base thereof through a linker comprising the structure
- ⁇ represents a point of attachment to a the base and ⁇ represents a point of attachment to the detectable marker
- a method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising:
- a method for determining the identity of each of a series of consecutive nucleotide residues in a self-priming nucleic acid comprising:
- steps b) and c) can be performed simultaneously, or in the order step b) then step c) or in the order step c) then step b).
- the nucleic acid is DNA and the nucleic acid polymerase is a 9°N thermopolymerase.
- the cleavable chemical group is a methylazido group.
- the four dNTP analogues have the following structures:
- nucleic acid is immobilized on a solid surface.
- solid surface is a chip or a bead.
- a method for determining the identity of each of a series of consecutive nucleotide residues in a plurality of nucleic acids comprising, the same series of consecutive nucleotides comprising:
- a method for determining the identity of consecutive nucleotide residues in a self-priming nucleic acid comprising:
- steps b) and c) can be performed simultaneously, or in the order step b) then step c) or in the order step c) then step b).
- the nucleic acid is DNA and the nucleic acid polymerase is a 9°N thermopolymerase.
- the cleavable chemical group is a methylazido group.
- the four ddNTP analogues have the following structures:
- the four dNTPs have the following structures:
- nucleic acid is immobilized on a solid surface.
- solid surface is a chip or a bead.
- a kit for use in sequencing a nucleic acid comprising:
- An array comprising a nucleic acid attached to a solid surface, wherein the nucleic acid comprises an azidomethyl group attached to a 3′ atom thereof and a molecule having the structure:
- ⁇ represents a point of attachment to a 3′ base of the nucleic acid and ⁇ represents a point of attachment to a detectable marker.
- An array comprising a self-priming nucleic acid attached to a solid surface, wherein the nucleic acid comprises an azidomethyl group attached to a 3′ atom thereof and a molecule having the structure:
- ⁇ represents a point of attachment to a 3′ base of the nucleic acid and ⁇ represents a point of attachment to a detectable marker.
- the detectable marker is a fluorophore.
- a method for increasing a read length of DNA sequencing by synthesis coupled with Sanger dideoxynucleotide terminating reaction (a) providing deoxynucleotide triphosphate analogues wherein the deoxynucleotide triphosphate analogues differ from deoxynucleotide triphosphates by having a methylazido group attached to a 3′ atom thereof and providing dideoxynucleotide triphosphate analogues wherein the dideoxynucleotide triphosphate analogues differ from dideoxynucleotide triphosphates by having a detectable marker attached to a 1 nitrogen or a 9 nitrogen of a base thereof through a linker comprising the structure
- This invention provides the instant method, wherein the detectable bound to the base via a cleavable linker is a dye, a fluorophore, a chromophore, a combinatorial fluorescence energy transfer tag, a mass tag, or an electrophore.
- a cleavable linker is a dye, a fluorophore, a chromophore, a combinatorial fluorescence energy transfer tag, a mass tag, or an electrophore.
- Combinatorial fluorescence energy tags and methods for production thereof are disclosed in U.S. Pat. No. 6,627,748, which is hereby incorporated by reference.
- This invention also provides the instant method, wherein the primer is a self-priming moiety.
- This invention also provides the instant method, wherein the DNA is bound to a solid substrate.
- This invention also provides the instant method, wherein the DNA is bound to the solid substrate via 1,3-dipolar azide-alkyne cycloaddition chemistry.
- This invention also provides the instant method, wherein the DNA is bound to the solid substrate via a polyethylene glycol molecule.
- This invention also provides the instant method, wherein the DNA is alkyne-labeled.
- This invention also provides the instant method, wherein the DNA is bound to the solid substrate via a polyethylene glycol molecule and the solid substrate is azide-functionalized.
- This invention also provides the instant method, wherein the DNA is immobilized on the solid substrate via an azido linkage, an alkynyl linkage, or biotin-streptavidin interaction. Immobilization of nucleic acids is described in Immobilization of DNA on Chips II, edited by Christine Wittmann (2005), Springer Verlag, Berlin, which is hereby incorporated by reference.
- This invention also provides the instant methods, wherein the DNA is bound to the solid substrate via a polyethylene glycol molecule and the solid substrate is azide-functionalized or the DNA is immobilized on the solid substrate via an azido linkage, an alkynyl linkage, or biotin-streptavidin interaction.
- the DNA or nucleic acid is attached/bound to the solid surface by covalent site-specific coupling chemistry compatible with DNA.
- This invention also provides the instant method, wherein the solid substrate is in the form of a chip, a bead, a well, a capillary tube, a slide, a wafer, a filter, a fiber, a porous media, or a column.
- the solid substrate is gold, quartz, silica, plastic, glass, nylon, diamond, silver, metal, or polypropylene.
- This invention also provides the instant method, wherein the solid substrate is porous.
- Chips or beads may be made from materials common for DNA microarrays, for example glass or nylon. Beads/micro-beads may be in turn immobilized to chips.
- This invention also provides the instant method, wherein about 1000 or fewer copies of the DNA are bound to the solid substrate.
- This invention also provides the instant invention wherein 2 ⁇ 10 7 , 1 ⁇ 10 7 , 1 ⁇ 10 6 or 1 ⁇ 10 4 or fewer copies of the DNA are bound to the solid substrate.
- nucleotide analogues comprise one of the fluorophores Cy5, Bodipy-FL-510, ROX and R6G.
- DNA polymerase is a 9°N polymerase or a variant thereof.
- DNA polymerases which can be used in the instant invention include, for example E. Coli DNA polymerase I, Bacteriophage T4 DNA polymerase, SequenaseTM, Taq DNA polymerase and 9°N polymerase (exo-) A485L/Y409V.
- RNA polymerases which can be used in the instant invention include, for example, Bacteriophage SP6, T7 and T3 RNA polymerases.
- a method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising:
- linker in each of step a) and j) independently each comprise the structure:
- a linker is cleaved by contacting the linker with tris(2-carboxyethyl)phosphine.
- one or more linkers are photocleavable or chemically cleavable.
- one or more chemical groups are photocleavable or chemically cleavable.
- R in the structures set forth in steps a) and or j) is independently chosen from a —N 3 group or an allyl group.
- the cleavable chemical group in step g) is independently chosen from a —N 3 group or an allyl group.
- a method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising:
- the three types of dNTPs are chosen from the group dATP, dCTP, dGTP, dTTP or dITP.
- linker in each of step a) and j) independently each comprise the structure:
- a linker is cleaved by contacting the linker with tris(2-carboxyethyl)phosphine.
- one or more linkers are photocleavable or chemically cleavable.
- one or more chemical groups are photocleavable or chemically cleavable.
- R in the structures set forth in steps a) and or j) is independently chosen from a —N 3 group or an allyl group.
- the cleavable chemical group in step g) is independently chosen from a —N 3 group or an allyl group.
- a method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising:
- step g) the three types of dNTPs are chosen from the group dATP, dCTP, dGTP and dTTP.
- linker in each of step a) and j) independently each comprise the structure:
- a linker is cleaved by contacting the linker with tris(2-carboxyethyl)phosphine.
- one or more linkers are photocleavable or chemically cleavable.
- one or more chemical groups are photocleavable or chemically cleavable.
- R in the structures set forth in steps a) and or j) is independently chosen from a —N 3 group or an allyl group.
- the cleavable chemical group in step g) is independently chosen from the a —N 3 group or an allyl group.
- the methods described herein can be applied mutatis mutandis to sequencing RNA using the appropriate ddNTPS or analogues thereof and dNTPS and analogues thereof.
- base-pairing complementarity allows the sequence of the extended primer or of the target nucleic to be readily determined.
- Hybridize is understood by those skilled in the art to mean to disassociate the hybridized primer (or extended strand thereof) from the target nucleic acid without destroying the target nucleic acid and thus permitting further hybridization of a second primer to the target nucleic acid.
- Hybridization as used herein in one embodiment means stringent hybridization, for examples as described in Sambrook, J., Russell, D. W., (2000) Molecular Cloning: A Laboratory Manual: Third Edition.
- Type of dNTP or ddNTP is used to distinguish dNTP or ddNTPs comprising different bases.
- 3′-O-Allyl-dNTPs and 3′-O-photocleaveble linker(PC)-dNTPs have offered concrete evidence for their implementation in sequencing by synthesis (SBS), a new set of nucleotide analogs, modified with the small azido group (N 3 ), is investigated to seek potential improvement over the current system.
- SBS sequencing by synthesis
- N 3 small azido group
- an azido group can be effectively converted into an amine with phosphine in DNA-friendly aqueous solution (35).
- This efficient reduction is further enhanced through the utilization of Tris(2-Carboxyethyl) phosphine (TCEP), an odorless and stable agent often used to digest peptide disulfide bonds ( FIG. 1 ).
- TCEP Tris(2-Carboxyethyl) phosphine
- nucleotide Similar to allyl and nitrobenzyl alterations previously reported, two positions of the nucleotide need to be modified with the azido moiety to afford a set of 3′-O-Azido-dNTPs-Azido-Dye.
- the small azido methyl group (—CH 2 —N 3 ) is used to cap the 3′ position of the sugar base while a novel azido linker connects unique fluorophores to the 5′ position of C/U and the 7′ position of A/G (see novel structures in FIG. 2 ).
- TCEP reagent
- Staudinger TCEP reduces the azido-methyl capping group to methylamine at the 3′ sugar base. Since the carbon of the methylamine is highly unstable due to its position between two electron-withdrawing elements (oxygen and nitrogen), the methylamine is hydrolyzed in the presence of water that recovers the hydroxyl group at the 3′ position. For the azido linker, the same Straudinger reduction takes place. However immediately after the attachment of TCEP to azido, the intermediate attacks the ester bond to afford total cleavage of the fluorophore ( FIG. 3 ).
- an alternative approach is to attach the fluorophore via a PC (nitrobenzyl) linker while conserving the 3′ capping with the azido methyl group (3′-O-Azido-dNTPs-PC-Dye, FIG. 4 ) and cleaving the azido again using TCEP.
- extension and detection steps for this set of nucleotides are analogous to those for 3′-O-Azido-dNTPs-Azido-Dye.
- An additional photolysis procedure is involved during the deprotection step. This dual cleavage process might offer different advantages for removing the fluorophore than the Staudinger reduction.
- nucleotides modified as reversible terminators by capping the 3′-OH with a small reversible moiety so that they are still recognized as substrates by DNA polymerase, are used in combination with a small percentage of four cleavable fluorescent dideoxynucleotides to perform SBS.
- DNA sequences are determined by the unique fluorescence emission of each fluorophore on the DNA products terminated by ddNTPs.
- the polymerase reaction reinitiates to continue the sequence determination ( FIG. 5 ).
- primer resetting The fundamental rationale behind primer resetting is to regenerate the original primer site or to insert two or more primer sites of known sequences into the target DNA so SBS can be carried out at each site sequentially.
- three steps are involved with this approach: 1) annealing of the first primer, 2) performing SBS, 3) denaturing the sequenced section of the template to recover a single-stranded DNA for the second primer annealing. These steps are carried out repeatedly until the target DNA is sequenced in its entirety.
- the advantage of primer resetting lies in its ability to restore all the templates after the denaturation step, including those that are terminated with ddNTPs, so the next cycle of SBS can restart with potentially the same amount of sequenceable DNA as the previous round.
- the DNA sequence is reset by reattaching the original primer, extending the chain with natural or minimally modified nucleotides to the end of the first round sequence, and then sequencing from that point.
- the second strategy relies on annealing of a second round primer that is longer than the first, containing at its 5′ end the same sequence as the original primer, followed by a run of 20 universal nucleotides such as inosine, from which the second round of sequencing can be primed.
- the two chemically cleavable fluorescent nucleotide analogs were used in an SBS reaction to identify the sequence of a self-primed DNA template (130 base pairs) immobilized on a solid surface.
- a reaction mixture of 3′-O-Azido-dCTP-Azido-BodipyFL, 3′-O-Azido-dUTP-Azido-R6G, 3′-O-Azido-dATP, and 3′-O-Azido-dGTP were prepared for the incorporation.
- a synchronization step was performed with the full set of 3′-O-Azido-dNTPs after incorporation to extend any remaining priming strand.
- sequencing by synthesis of DNA templates attached on solid surface will be carried out.
- the goal will be the achievement of maximum base read length of each template with high consistency.
- 3′-O-azidomethyl-modified NRTs (3′-O—N 3 -dNTPs) ( FIG. 6 ) were synthesized and evaluated for the hybrid SBS.
- the 3′-O-azidomethyl group on the DNA extension product generated by incorporating each of the NRTs was efficiently removed by the Staudinger reaction by using aqueous Tris(2-carboxyethyl) phosphine (TCEP) solution (36,37) followed by hydrolysis to yield a free 3′-OH group for elongating the DNA chain in subsequent cycles of the hybrid SBS ( FIG. 13A ).
- TCEP Tris(2-carboxyethyl) phosphine
- ddNTP-N 3 -fluorophores four cleavable fluorescent dideoxynucleotides ddNTP-N 3 -fluorophores (ddCTP-N 3 -Bodipy-FL-510, ddUTP-N 3 -R6G, ddATP-N 3 -ROX, and ddGTP-N 3 -Cy5) were synthesized ( FIGS. 14-22 ). The ddNTP-N 3 -fluorophores would be combined with the 4 NRTs ( FIG. 6 ) to perform the hybrid SBS.
- Modified DNA polymerases have been shown to be highly tolerant to nucleotide modifications with bulky groups at the 5 position of pyrimidines (C and U) and the 7 position of purines (A and G) (27).
- C and U pyrimidines
- a and G purines
- a unique fluorophore was attached to the 5 position of C/U and the 7 position of A/G through a cleavable linker, which is also based on an azido-modified moiety (37) as a trigger for cleavage, a mechanism that is similar to the removal of the 5′-O-azidomethyl group ( FIG. 13B ).
- the ddNTP-N 3 -fluorophores are found to efficiently incorporate into the growing DNA strand to terminate DNA synthesis for sequence determination.
- the fluorophore on a DNA extension product which is generated by incorporation of the cleavable fluorescent ddNTPs, is removed rapidly and quantitatively by TCEP from the DNA extension
- the MALDI-TOF MS spectrum consist of a distinct peak corresponding to the DNA extension product 5′-primer-C—N 3 3′ (m/z 8,310), which confirms that the NRT can be incorporated base-specifically by DNA polymerase into a growing DNA strand.
- FIG. 19(B) shows the cleavage result on the DNA extension product. The extended DNA mass peak at m/z 8,310 completely disappeared, whereas the peak corresponding to the cleavage product 5′-primer-C-3′ appears as the sole dominant peak at m/z 8,255, which establishes that TCEP incubation completely cleaves the 3′-O-azidomethyl group with high efficiency.
- the next extension reaction was carried out by using this cleaved product, which now has a free 3′-OH group, as a primer to yield a second extension product, 5′-primer-CGN 3 -3′ (m/z 8,639; FIG. 19C ).
- the extension product was cleaved to generate product for further MS analysis yielding a single peak at m/z 8,584 ( FIG. 19(D) ).
- FIGS. 20 A, C, E, and G Single clear mass peaks at 9,180, 8,915, 9,317, and 9,082 (m/z) corresponding to each primer extension product with no leftover starting materials were produced by using ddNTP-N 3 -fluorophores.
- FIGS. 20 A, C, E, and G Brief incubation of the DNA extension products in an aqueous TCEP solution led to the cleavage of the linker tethering the fluorophore to the dideoxynucleotide.
- FIGS. 20 B, D, F, and H shows the cleavage results for the DNA products extended with ddNTP-N 3 -fluorophores.
- the identity of the incorporated nucleotide is determined by the unique fluorescent emission from the four fluorescent dideoxynucleotide terminators, while the role of the 3′-O-modified NRTs is to further extend the DNA strand to continue the determination of the DNA sequence. Therefore, the ratio between the amount of ddNTP-N 3 -fluorophores and 3′-O—N 3 -dNTPs during the polymerase reaction determines how much of the ddNTP-N 3 -fluorophores incorporate and thus the corresponding fluorescent emission strength.
- De novo sequencing reaction on the chip was initiated by extending the self-priming DNA by using a solution consisting of four 3′-O—N 3 -dNTPs and four ddNTP-N 3 -fluorophores, and 9°N DNA polymerase.
- the hybrid SBS allows for the addition of all eight, nucleotide substrates simultaneously to unambiguously determine DNA sequences. This reduces the number of steps needed to complete the sequencing cycle, while increasing the sequencing accuracy because of competition among the substrates in the polymerase reaction.
- the DNA products extended by ddNTP-N 3 -fluorophores, after fluorescence detection for sequence determination and cleavage, are no longer involved in the subsequent polymerase reaction cycles because they are permanently terminated.
- a synchronization step was added to reduce the amount of unextended priming strands after the initial extension reaction shown in the scheme of FIG. 21A .
- a synchronization reaction mixture consisting of just the four 3′-O—N 3 -dNTPs in relatively high concentration was used along with the 9°N DNA polymerase to extend, any remaining priming strands that retain a free 3′-OH group to synchronize the incorporation.
- FIG. 21B The four-color images from a fluorescence scanner for each step of the hybrid SBS on a chip is shown in FIG. 21B .
- the surface was immersed in a TCEP solution to cleave both the fluorophore from the DNA product extended with ddNTP-N 3 -fluorophores and the 3′-O-azidomethyl group from the DNA product extended with 3′-O—N 3 -dNTPs.
- walking The fundamental rationale behind this template “walking” strategy is the removal of the sequenced strand and reattaching of the original primer to allow the extension, or walking, of the template with a combination of natural and modified nucleotides to the end of the first round sequence so that SBS can be carried out from that point. Since the original sequenced strand is stripped away, including those terminated with ddNTPs, all the templates become available for “walking”. Given that “walking” is carried out with either natural or 3′-modified nucleotides, the subsequent round of SBS is performed on nascent DNA strands for maximum read length.
- the advantage of template “walking” is its ability to restore all the templates after the denature step, includes those that are terminated with ddNTPs, so the next cycle of SBS can restart with potentially the same amount of nascent DNA as the previous round.
- the “walking” methodology is applicable to both hybrid SBS and SBS with C—F-NRTs, and has the potential to dramatically increase the read lengths of these SBS technologies ( FIG. 23 ).
- DNA sequencing by synthesis offers a paradigm to efficiently decipher multiple DNA sequences in parallel.
- Hybrid SBS is a hybrid DNA sequencing method between the Sanger dideoxy chain terminating reaction and SBS.
- four nucleotides FIG. 24
- four nucleotides FIG. 24
- FIG. 25 a small percentage of four cleavable fluorescent dideoxynucleotides
- Sequences are determined by the unique fluorescence emission of each fluorophore on the DNA products terminated by ddNTPs, while the role of the 3′-O-modified dNTPs is to further extend the DNA strand to continue the determination of the DNA sequence.
- the polymerase reaction Upon removing the 3′-OH capping group from the DNA products generated by incorporating the 3′-O-modified dNTPs and the fluorophore from the DNA products terminated with the ddNTPs, the polymerase reaction reinitiates to continue the sequence determination ( FIG. 26 ).
- the second stage of SBS is conducted using mixture of nucleotide reversible terminators and fluorescently labeled dideoxynucleotides as incorporation substrates same as described above. Another cluster of bases on the template can be continuously revealed, leading to the doubling of the original read length.
- the SBS-walking-SBS process is repeated to generate maximum read length.
- 3′-O-azidomethyl-modified NRTs (3′-O—N 3 -dNTPs) were synthesized and evaluated ( FIG. 32 ) for use in the hybrid SBS approach.
- the 3′-O-modified NRTs containing an azidomethyl group to cap the 3′-OH on the sugar ring were synthesized based on similar method to that reported by Zavgorodny et al.
- the 3′-O-azidomethyl group on the DNA extension product generated by incorporating each of the NRTs is efficiently removed by the Staudinger reaction using aqueous Tris(2-carboxy-ethyl) phosphine (TCEP) solution followed by hydrolysis to yield a free 3′-OH group for elongating the DNA chain in subsequent cycles of the hybrid SBS ( FIG. 34A ).
- TCEP Tris(2-carboxy-ethyl) phosphine
- ddNTP-N 3 -Fluorophores ddCTP-N 3 -Bodipy-FL-510, ddUTP-N 3 -R6G, ddATP-N 3 -ROX and ddGTP-N 3 -Cy5 ( FIG. 33 ).
- the ddNTP-N 3 -Fluorophore were used in combination with the four NRTs ( FIG. 32 ) to perform the hybrid SBS.
- Modified DNA polymerases have been shown to be highly tolerant to nucleotide modifications with bulky groups at the 5-position of pyrimidines (C and U) and the 7-position of purines (A and G). Thus, a each unique fluorophore was attached to the 5 position of C/U and the 7 position of A/G through a cleavable linker.
- the cleavable linker is also based on an azido modified moiety as a trigger for cleavage, a mechanism that is similar to the removal of the 3′-O-azidomethyl group ( FIG. 34B ).
- Hybrid SBS was performed on a chip-immobilized DNA template using the 3′-O—N 3 -dNTP/ddNTP-N 3 -fluorophore combination and the results are shown in FIG. 35 .
- the general four-color sequencing reaction scheme on a chip is shown in FIG. 35A .
- the de novo sequencing reaction on the chip was initiated by extending the self-priming DNA using a solution containing the combination of the four 3′-O—N 3 -dNTPs and the four ddNTP-N 3 -fluorophores, and 9°N DNA polymerase.
- the four-color images from a fluorescence scanner for each step of the hybrid SBS on a chip is shown in FIG. 35B .
- the entire process of incorporation, synchronization, detection and cleavage was performed multiple times to identify 32 successive bases in the DNA template.
- the plot of the fluorescence intensity vs. the progress of sequencing extension (raw 4-color sequencing data) is shown in FIG. 35C .
- the DNA sequences were unambiguously identified with no errors from the 4-color raw fluorescence data without any processing.
- the same self-priming DNA was immobilized on surface as template.
- the primer was reset for the second round SBS by elongating the original primer over the sequenced region via enzymatic incorporations.
- 9°N DNA polymerase incorporates 3′ unblocked nucleotides more efficiently, leading to certain percentage of primers not fully extended by 3′-O—N 3 -dGTP. To minimize this effect, a synchronization step was added to reduce the amount of out-of-phase primers after the initial extension reaction.
- a synchronization reaction mixture consisting of just 3′-O—N 3 -dGTP in relative high concentration was used along with the 9°N DNA polymerase.
- the 3′-O-azidomethyl group on the DNA extension product generated by incorporating 3′-O—N 3 -dGTP was efficiently removed by using aqueous Tris(2-carboxy-ethyl) phosphine (TCEP) solution to yield a free 3′-OH group for elongating the DNA chain in subsequent cycles of enzymatic incorporation.
- TCEP Tris(2-carboxy-ethyl) phosphine
- the second stage of SBS was conducted using mixture of nucleotide reversible terminators and fluorescently labeled dideoxynucleotides as incorporation substrates same as described above. Another 13 bases were successfully identified after template “walking” ( FIG. 14 ).
- DNA sequencing by synthesis offers a paradigm to efficiently decipher multiple DNA sequences in parallel.
- SBS DNA sequencing by synthesis
- C—F-NRTs modified cleavable fluorescent nucleotide reversible terminators
- C-NRTs 3′-O—R 1 -dNTPs-R 2 -fluorophore
- a set of four C—F-NRTs is produced via dual modifications by capping the 3′-OH group with a small chemical moiety and tethering a fluorophore through a cleavable linker to either the 7-position of the purines (A, G) or the 5-position of the pyrimidines (C, T) so that they are still recognized as substrates by DNA polymerase.
- Another set of four C-NRTs is modified similarly as the C—F-NRTs except no fluorophore is attached, which results in a reduction of the size of C-NRTs and the increment of DNA polymerase incorporation efficiency.
- an extension mixture composed of the C-NRTs with a small percentage of the C—F-NRTs is used to perform SBS. Sequences are determined by the unique fluorescence emission of each fluorophore on the DNA products terminated by the C—F-NRTs. Immediately following the detection step, a synchronization reaction is performed using only the C-NRTs to extend the un-extended DNA strands. A dideoxynucleotides (ddNTPs) capping step is carried out afterwards to completely rid of the remaining un-extended DNA.
- ddNTPs dideoxynucleotides
- the polymerase reaction Upon removing the 3′-OH capping group from the DNA products generated by incorporating both C—F-NRTs and C-NRTs and the fluorophore from the C—F-NRTs, the polymerase reaction reinitiates to continue the sequence determination.
- the following scheme ( FIG. 37 ) illustrates the general process for SBS with C—F-NRTs.
- the azidomethyl capping moiety on the 3′-OH and the fluorophore attached to the DNA extension product via the azido-based cleavable linker are efficiently removed using tris(2-carboxyethyl)phosphine (TCEP) in aqueous solution compatible with DNA.
- TCEP tris(2-carboxyethyl)phosphine
- DNA templates are denatured by heat or mild alkali conditions to rid of the extended primer.
- the same original primer is re-hybridized to the template chain, and one of the five “walking” methods described in the previous section can be applied to reset the start point for the next round of SBS at the end of the first sequencing run ( FIGS. 40 , 41 , 42 , 43 , and 44 ).
- the primer is extended to the end of the previous round of SBS.
- hybrid SBS is carried out to identify the subsequent bases. If the process can be repeated more times, it should be theoretically possible to achieve long and significant read length.
- the reset is achieved not with nucleotide walking, but with the use of a longer primer partially consisting of universal nucleotides for the second round. Attachment of the template DNA to the surface and the first few steps of the procedure are identical to the first method. However, after stripping the first extended primer for the initial 20 base readout, a long primer with the following features will be hybridized to the template: (a) the first half is identical to the initial primer; (b) the second half is composed almost entirely of universal bases.
- the universal base is inosine, which, in its deoxynucleoside form, can base pair with all four nucleotides, though its affinity for C and A is significantly higher than for G and T; a second possibility is 5-nitroindole; (c) the last one or two anchoring bases of the long primers are degenerate with each of the four possible bases being represented. Because the universal bases can form hydrogen bonds with any of the other four bases with some efficiency, they have the capacity to bind to the first 20 or so bases of the sequence. However, the melting temperature of the ensuing hybridization is reduced substantially by the run of inosines, a few of the bases in the first half and the two 3′-anchoring bases can be substituted with locked nucleotides.
- Locked nucleic acids have a chemical bond between the 2′ and 4′ carbons of the ribose. While slower to associate with their complementary base, once hybridized, they tend not to dissociate. Thus, they provide a nice solution to ensure that the long primer remains attached appropriately to the template. In addition, the percentage of locked nucleosides in the primer can be manipulated to achieve higher hybridization strength. After hybridization of the above long primer, a second round of either Hybrid SBS or SBS with C—F—NRTs can be performed ( FIG. 45 ).
- an alternative approach to Strategy 2 is the use of a detachable loop primer, possibly with a labile sugar and glycosylase treatment.
- the loop is removed by enzymatic cleavage and denaturation, and then a new identical loop is attached.
- the new loop primer can be composed of an initial portion identical to the first loop primer, a “loop out” region that bypasses the first set of sequenced nucleotides, and a degenerate anchoring nucleotide to initiate the second round of sequencing.
- one or two additional primer annealing sites are introduced into the DNA to be sequenced at a distance just about equal to the number of bases that can be sequenced from the first primer.
- template preparation for SBS will utilize the cloning of genomic DNA into a specially designed vector containing type IIS or III restriction sites (MmeI and EcoP15 I) flanking the genomic DNA cloning site.
- size fractionated DNA minimum length 100 bp
- the resulting recombinant plasmids will be re-cut at one of the type IIS/III sites and the sticky ends will be filled in with Klenow enzyme.
- specific sequencing primers will be introduced via ligation inside the genomic DNA inserts, 22 bases distant from the first primer in the case of MmeI or 27 bases away in the case of EcoP15 I.
- the constructs After insertion of the internal priming sites, the constructs will be re-cloned in E. coli , the recombinant plasmids isolated and the inserts re-amplified by PCR at vector-insert junctions and attached to the beads for sequencing.
- emulsion or polony PCR strategies can be used to accomplish attachment of single molecules to individual beads or slide locations and their subsequent amplification at a much lower cost than cloning.
- the first round of Hybrid SBS or SBS with C—F-NRTs will be primed from the flanking primer, then after stripping these extended primers, the second set of sequencing reactions will be initiated at the internal primer. It should be noted that with this scheme, the two sequenced portions come from opposite ends of the initial DNA, and are in essence paired end reads.
- the extra cycles would enable some of the sequence reads to run into the next primer, which would help to confirm the direction (e.g., the last sequence might end with the MmeI or EcoP15I site.
- Other tricks would include modifying the ends of the primers to allow looping and reverse direction sequencing, incorporation of one or two decoding bases in the internal primers to confirm directions, and deconvoluting the results after all the data is generated.
- the four NRTs (3′-O—N 3 -dATP, 3′-O—N 3 -dCTP, 3′-O—N 3 -dGTP and 3′-O—N 3 -dTTP) have been characterized, by performing four continuous DNA-extension reactions sequentially using a self-priming DNA template (5′-ATCGGCGCCGCGCCTTGGCGCGGCGC-3′ (SEQ ID No:1).
- the four nucleotides in the template immediately adjacent to the annealing site of the primer are 3′-GCTA-5′, which allows the evaluation of the incorporation and cleavage efficiency of the 4 NRTs.
- a polymerase extension reaction using a pool of all four NRTs along with the self-priming DNA template was performed producing a single base extension product.
- the reaction mixture for this, and all subsequent extension reactions consisted of 80 pmol of self-priming DNA template, 160 pmol of 3′-O—N 3 -dNTPs, 1 ⁇ Thermopol II reaction buffer (New England Biolabs), 40 nmol of MnCl 2 and 1 unit of 9°N DNA polymerase (exo-) A485L/Y409V (New England Biolabs) in a total reaction volume of 20 ⁇ l.
- the reaction consisted of incubation at 94° C. for 5 min, 4° C. for 5 min, and 65° C. for 20 min.
- extension product was desalted by using a ZipTip and analyzed by Voyager DE MALDI-TOF mass spectrometry (Applied Biosystems).
- the desalted DNA extension product bearing the 3′-O-azidomethyl group was first resuspended with 5 ⁇ l of 50 mM EDTA solution to quench the polymerase activity.
- This DNA solution was then mixed with 10 ⁇ l of 225 mM TCEP solution (pH 9.0) and incubated at 65° C. for 15 min to yield a cleaved DNA product which was characterized by MALDI-TOF MS.
- the DNA product with the 3′-O-azidomethyl group removed to generate a free 3′-OH group was purified by using an Oligonucleotide Purification Cartridge (Applied Biosystems) and used as a primer for a second extension reaction using 3′-O—N 3 -dNTPs.
- the second extended DNA product was then purified by ZipTip and cleaved as described above.
- the third and the fourth extensions were carried out in a similar manner by using the previously extended and cleaved product as the primer.
- ddNTP-N3-fluorophores ddCTP-N3-Bodipy-FL-510, ddUTP-N3-R6G, ddATP-N3-ROX, and ddGTP-N3-Cy5
- ddNTP-N3-fluorophores ddCTP-N3-Bodipy-FL-510, ddUTP-N3-R6G, ddATP-N3-ROX, and ddGTP-N3-Cy5
- Each of the extension reactions consisted of all four ddNTP-N 3 -fluorophores (e.g., 120 pmol each of ddCTP-N 3 -Bodipy-FL-510, ddUTP-N 3 -R6G, ddATP-N 3 -ROX, and ddGTP-N 3 -Cy5) along with 60 pmol of the self-priming DNA template, 1 ⁇ Thermopol II reaction buffer, 40 nmol of MnCl 2 and 1 unit of 9°N DNA polymerase (exo-) A485L/Y4Q9V in a total reaction volume of 20 ⁇ l.
- the reaction consisted of incubations at 94° C. for 5 min, 4° C.
- the extension product was purified by reverse-phase HPLC using established procedures (40). The fraction containing the desired product was collected and freeze-dried for analysis by MALDI-TOF MS and cleavage.
- the purified DNA product was resuspended in 50 ml of 100 mM TCEP solution (pH 9.0) at 65° C. for 15 min and then analyzed by MALDI-TOF MS.
- the nucleotide complementary to the DNA template was allowed to incorporate into the primer at 62° C. for 15 min.
- an extension solution consisting of 38 pmol each of 3′-O—N 3 -dTTP, 3′-O—N 3 -dATP, 3′-O—N 3 -dGTP and 75 pmol of 3′-O—N 3 -dCTP, 1 unit of 9°N mutant DNA polymerase(exo-) A485L/Y409V, 20 nmol of MnCl 2 and 1 ⁇ Thermopol II reaction buffer was added to the same spot and incubated at 62° C. for 15 min.
- the chip After washing with SPSC buffer containing 0.1% Tween 20 for 1 min, the chip was rinsed with dH 2 O, and then scanned with a 4-color fluorescence ScanArray Express scanner (Perkin-Elmer Life Sciences) to detect the fluorescence signal. To perform the cleavage, the DNA chip was placed inside a chamber filled with 100 mM TCEP (pH 9.0) and incubated at 65° C. for 10 min. After washing the surface with dH 2 O, the chip was scanned again to measure the background fluorescence signal.
- TCEP pH 9.0
- the 5′-amino-labeled self-priming DNA template 5′-NH 2 -CAC-TCA-CAT-ATG-TTT-TTT-AGC-TTT-TTT-AAT-TTC-TTA-ATG-ATG-TTG-TTG-CAT-GCG-ACT-TAA-GGC-GCT-TGC-GCC-TTA-AGT-CG-3′ (SEQ ID No:6) was purchased from IDT (Coralville, Iowa).
- the DNA template was dissolved at 40 ⁇ M in 50 mM sodium phosphate buffer, pH 8.5 and spotted using SpotArray 72 arraying robot (Perkin Elmer) onto high density CodeLink microarray slides (GE Healthcare).
- the slides were incubated at ambient temperature ( ⁇ 24° C.) for 20 hours in a humid chamber containing saturated sodium chloride solution ( ⁇ 75% humidity) to allow for 5′-tethering of the spotted amino-modified DNA templates to the slide surface functionalized with succinimide ester groups.
- the slides were removed from the humid chamber and stored in vacuum desiccator at room temperature until further use.
- the principal advantage of the hairpin structure introduced into the 3′-portion of the self-priming DNA template is its higher stability and the increased priming efficiency for DNA polymerases as compared to a separate primer/template complex, which is prone to spontaneous dissociation.
- the SBS cycle was repeated multiple times using the combination mixture of solution A consisting of 3′-O—N 3 -dCTP (3 ⁇ M), 3′- ⁇ -N 3 -dTTP (3 ⁇ M), 3′-O—N 3 -dATP (3 ⁇ M) and 3′-O—N 3 -dGTP (0.5 ⁇ M) and solution B consisting of ddCTP-N 3 -Bodipy-FL-510 (50 nM), ddUTP-N 3 -R6G (100 nM), ddATP-N 3 -ROX (200 nM) and ddGTP-N 3 -Cy5 (100 nM) in each polymerase extension reaction.
- solution A and B in each SBS cycle were used to achieve relatively even fluorescence signals.
- 3′-O-modified cleavable reversible terminator nucleotides (3′-O—N 3 -dNTPs) along with four fluorescent ddNTPs have been synthesized and characterized, and used them to produce 4-color de novo DNA sequencing data on a chip by Sanger/SBS hybrid sequencing approach that has the following advantages.
- 3′-O—N 3 -dNTPs After cleavage of the 3′OH capping group of the DNA extension product, there are no traces of modification left on the growing DNA strand. Therefore, there are no adverse effects on the DNA polymerase for incorporation of the next complementary nucleotide.
- the cleavable fluorescent ddNTPs and 3′-O—N 3 -dNTPs permanent and reversible terminators, respectively, which allow the interrogation of each base in a serial manner, a key procedure enabling accurate determination of homopolymeric regions of DNA.
- all of the steps of the nucleotide incorporation, fluorescence detection for sequence determination, cleavage of the fluorophore, and the 3′-O-azidomethyl group are performed on a DNA chip, there is no longer a need for electrophoretic DNA fragment separation as in the classical Sanger sequencing method.
- the identity of the incorporated nucleotide is determined by the unique fluorescence emission from the four fluorescent dideoxynucleotides, whereas the role of the 3′-O-modified NRTs is to further extend the DNA strand. Therefore, the ratio of the ddNTP-N 3 -fluorophores and 3′-O—N 3 -dNTPs during the polymerase reaction determines how much of the ddNTP-N 3 -fluorophores incorporate and, thus, the corresponding fluorescence emission strength.
- the majority of the priming strands should be extended with 3′-O—N 3 -dNTPs, whereas a relatively smaller amount should be extended with ddNTP-N 3 -fluorophores to produce sufficient fluorescent signals that are above the fluorescence detection system's sensitivity threshold for sequence determination.
- the amount of the ddNTP-N 3 -fluorophores needs to be gradually increased to maintain the fluorescence emission strength for detection.
- the signal strength at base 32 is as strong as that of the first base ( FIG. 21C ), indicating it should be possible to increase the read length of the hybrid SBS further by optimizing the extension conditions to reduce the background fluorescence in the later sequencing cycles.
- the ultimate read length of this hybrid SBS system depends on three factors: the number of starting DNA molecules on each spot of a DNA chip, the reaction efficiency, and the detection sensitivity of the system.
- the read length with the Sanger sequencing method commonly reaches >700 bp.
- the hybrid SBS approach described here may have the potential to reach this read length, especially with improvements in the sensitivity of the fluorescent detection system, where single molecules can be reliably detected.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/734,227 US20110014611A1 (en) | 2007-10-19 | 2008-10-17 | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99957607P | 2007-10-19 | 2007-10-19 | |
US12/734,227 US20110014611A1 (en) | 2007-10-19 | 2008-10-17 | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis |
PCT/US2008/011891 WO2009051807A1 (en) | 2007-10-19 | 2008-10-17 | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/011891 A-371-Of-International WO2009051807A1 (en) | 2007-10-19 | 2008-10-17 | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/951,269 Continuation US9175342B2 (en) | 2007-10-19 | 2013-07-25 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110014611A1 true US20110014611A1 (en) | 2011-01-20 |
Family
ID=40567704
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/734,227 Abandoned US20110014611A1 (en) | 2007-10-19 | 2008-10-17 | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis |
US13/951,269 Active 2029-02-19 US9175342B2 (en) | 2007-10-19 | 2013-07-25 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US14/859,853 Active US9670539B2 (en) | 2007-10-19 | 2015-09-21 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US15/596,379 Active US10144961B2 (en) | 2007-10-19 | 2017-05-16 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US16/208,379 Active 2029-12-01 US11208691B2 (en) | 2007-10-19 | 2018-12-03 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US17/560,928 Pending US20220112552A1 (en) | 2007-10-19 | 2021-12-23 | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/951,269 Active 2029-02-19 US9175342B2 (en) | 2007-10-19 | 2013-07-25 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US14/859,853 Active US9670539B2 (en) | 2007-10-19 | 2015-09-21 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US15/596,379 Active US10144961B2 (en) | 2007-10-19 | 2017-05-16 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US16/208,379 Active 2029-12-01 US11208691B2 (en) | 2007-10-19 | 2018-12-03 | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US17/560,928 Pending US20220112552A1 (en) | 2007-10-19 | 2021-12-23 | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis |
Country Status (4)
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090263791A1 (en) * | 2005-10-31 | 2009-10-22 | Jingyue Ju | Chemically Cleavable 3'-O-Allyl-DNTP-Allyl-Fluorophore Fluorescent Nucleotide Analogues and Related Methods |
US20090298072A1 (en) * | 2006-06-07 | 2009-12-03 | The Trustees Of Columbia University In The City Of | DNA Sequencing by Nanopore Using Modified Nucleotides |
US20090325154A1 (en) * | 2005-06-21 | 2009-12-31 | The Trustees Of Columbia University In The City Of New York | Pyrosequencing Methods and Related Compositions |
US20110039259A1 (en) * | 2007-10-19 | 2011-02-17 | Jingyue Ju | Dna sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators |
WO2012162429A2 (en) * | 2011-05-23 | 2012-11-29 | The Trustees Of Columbia University In The City Of New York | Dna sequencing by synthesis using raman and infrared spectroscopy detection |
US8845880B2 (en) | 2010-12-22 | 2014-09-30 | Genia Technologies, Inc. | Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps |
US9133511B2 (en) | 2000-10-06 | 2015-09-15 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US9146248B2 (en) | 2013-03-14 | 2015-09-29 | Intelligent Bio-Systems, Inc. | Apparatus and methods for purging flow cells in nucleic acid sequencing instruments |
US9175342B2 (en) | 2007-10-19 | 2015-11-03 | The Trustees Of Columbia University In The City Of New York | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US9255292B2 (en) | 2005-10-31 | 2016-02-09 | The Trustees Of Columbia University In The City Of New York | Synthesis of four-color 3′-O-allyl modified photocleavable fluorescent nucleotides and related methods |
US9322062B2 (en) | 2013-10-23 | 2016-04-26 | Genia Technologies, Inc. | Process for biosensor well formation |
US9494554B2 (en) | 2012-06-15 | 2016-11-15 | Genia Technologies, Inc. | Chip set-up and high-accuracy nucleic acid sequencing |
US9528151B2 (en) | 2006-12-01 | 2016-12-27 | The Trustees Of Columbia University In The City Of New York | Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators |
WO2017019278A1 (en) * | 2015-07-30 | 2017-02-02 | Illumina, Inc. | Orthogonal deblocking of nucleotides |
WO2017027783A1 (en) * | 2015-08-13 | 2017-02-16 | Centrillion Technology Holdings Corporation | Methods for synchronising nucleic acid molecules |
US9591268B2 (en) | 2013-03-15 | 2017-03-07 | Qiagen Waltham, Inc. | Flow cell alignment methods and systems |
US9605309B2 (en) | 2012-11-09 | 2017-03-28 | Genia Technologies, Inc. | Nucleic acid sequencing using tags |
US9708358B2 (en) | 2000-10-06 | 2017-07-18 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10190162B2 (en) | 2014-10-23 | 2019-01-29 | Complete Genomics, Inc. | Signal confinement sequencing (SCS) and nucleotide analogues for signal confinement sequencing |
US10240195B2 (en) | 2014-03-24 | 2019-03-26 | The Trustees Of Columbia University In The City Of New York | Chemical methods for producing tagged nucleotides |
US10246479B2 (en) | 2012-04-09 | 2019-04-02 | The Trustees Of Columbia University In The City Of New York | Method of preparation of nanopore and uses thereof |
US10421995B2 (en) | 2013-10-23 | 2019-09-24 | Genia Technologies, Inc. | High speed molecular sensing with nanopores |
US10443096B2 (en) | 2010-12-17 | 2019-10-15 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by synthesis using modified nucleotides and nanopore detection |
US10648026B2 (en) | 2013-03-15 | 2020-05-12 | The Trustees Of Columbia University In The City Of New York | Raman cluster tagged molecules for biological imaging |
WO2020146397A1 (en) * | 2019-01-08 | 2020-07-16 | Singular Genomics Systems, Inc. | Nucleotide cleavable linkers and uses thereof |
US10732183B2 (en) | 2013-03-15 | 2020-08-04 | The Trustees Of Columbia University In The City Of New York | Method for detecting multiple predetermined compounds in a sample |
WO2020159447A1 (en) * | 2019-01-31 | 2020-08-06 | Agency For Science, Technology And Research | Method of synthesizing single-stranded nucleotide sequence, blocked nucleoside triphosphates and related methods |
US11085076B2 (en) | 2015-09-28 | 2021-08-10 | The Trustees Of Columbia University In The City Of New York | Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis |
US11174281B1 (en) | 2020-04-24 | 2021-11-16 | Singular Genomics Systems, Inc. | Modified nucleotides and uses thereof |
CN114958995A (zh) * | 2022-04-27 | 2022-08-30 | 深圳赛陆医疗科技有限公司 | 一种基因测序方法 |
US11591647B2 (en) | 2017-03-06 | 2023-02-28 | Singular Genomics Systems, Inc. | Nucleic acid sequencing-by-synthesis (SBS) methods that combine SBS cycle steps |
US11878993B2 (en) | 2018-10-25 | 2024-01-23 | Singular Genomics Systems, Inc. | Nucleotide analogues |
US11946103B2 (en) | 2021-12-10 | 2024-04-02 | Singular Genomics Systems, Inc. | Cleavable disulfide linkers and uses thereof |
US11970735B2 (en) | 2020-01-07 | 2024-04-30 | Singular Genomics Systems, Inc. | Nucleotide cleavable linkers and uses thereof |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11008359B2 (en) | 2002-08-23 | 2021-05-18 | Illumina Cambridge Limited | Labelled nucleotides |
EP2021415B1 (en) | 2006-05-18 | 2017-03-15 | Illumina Cambridge Limited | Dye compounds and the use of their labelled conjugates |
US10036063B2 (en) | 2009-07-24 | 2018-07-31 | Illumina, Inc. | Method for sequencing a polynucleotide template |
US8324914B2 (en) | 2010-02-08 | 2012-12-04 | Genia Technologies, Inc. | Systems and methods for characterizing a molecule |
US9678055B2 (en) | 2010-02-08 | 2017-06-13 | Genia Technologies, Inc. | Methods for forming a nanopore in a lipid bilayer |
US9605307B2 (en) | 2010-02-08 | 2017-03-28 | Genia Technologies, Inc. | Systems and methods for forming a nanopore in a lipid bilayer |
US9581563B2 (en) | 2011-01-24 | 2017-02-28 | Genia Technologies, Inc. | System for communicating information from an array of sensors |
US9110478B2 (en) | 2011-01-27 | 2015-08-18 | Genia Technologies, Inc. | Temperature regulation of measurement arrays |
SI3623481T1 (sl) * | 2011-09-23 | 2022-01-31 | Illumina, Inc. | Sestavki za sekvenciranje nukleinske kisline |
US8986629B2 (en) | 2012-02-27 | 2015-03-24 | Genia Technologies, Inc. | Sensor circuit for controlling, detecting, and measuring a molecular complex |
WO2013191793A1 (en) | 2012-06-20 | 2013-12-27 | The Trustees Of Columbia University In The City Of New York | Nucleic acid sequencing by nanopore detection of tag molecules |
US9759711B2 (en) | 2013-02-05 | 2017-09-12 | Genia Technologies, Inc. | Nanopore arrays |
US8754244B1 (en) | 2013-03-08 | 2014-06-17 | Illumina Cambridge Limited | Rhodamine compounds and their use as fluorescent labels |
CN104292117B (zh) * | 2013-07-15 | 2016-10-05 | 上海交通大学 | 酸敏感连接单元的合成及其在dna测序中的用途 |
US9551697B2 (en) | 2013-10-17 | 2017-01-24 | Genia Technologies, Inc. | Non-faradaic, capacitively coupled measurement in a nanopore cell array |
GB201414098D0 (en) | 2014-08-08 | 2014-09-24 | Illumina Cambridge Ltd | Modified nucleotide linkers |
US9933431B2 (en) | 2014-08-22 | 2018-04-03 | Arizona Board Of Regents On Behalf Of Arizona State University | System and method for iterative detection of biological molecules |
EP3268050B1 (en) | 2015-03-09 | 2021-07-14 | The Trustees of Columbia University in the City of New York | Pore-forming protein conjugate compositions and methods |
US11266673B2 (en) | 2016-05-23 | 2022-03-08 | The Trustees Of Columbia University In The City Of New York | Nucleotide derivatives and methods of use thereof |
WO2018102554A1 (en) * | 2016-12-01 | 2018-06-07 | President And Fellows Of Harvard College | Cleavable nucleotide analogs and uses thereof |
US11332787B2 (en) | 2018-06-29 | 2022-05-17 | Pacific Biosciences Of California, Inc. | Methods and compositions for delivery of molecules and complexes to reaction sites |
CA3130693A1 (en) | 2019-02-19 | 2020-08-27 | Ultima Genomics, Inc. | Linkers and methods for optical detection and sequencing |
WO2021007458A1 (en) * | 2019-07-09 | 2021-01-14 | The Trustees Of Columbia University In The City Of New York | Novel nucleotide analogues and methods for use |
US20210238577A1 (en) * | 2020-02-04 | 2021-08-05 | Microsoft Technology Licensing, Llc | Electrochemically-cleavable linkers |
US11807851B1 (en) | 2020-02-18 | 2023-11-07 | Ultima Genomics, Inc. | Modified polynucleotides and uses thereof |
CN114634488A (zh) * | 2020-12-15 | 2022-06-17 | 湖北华大基因研究院 | 琥珀酰亚胺酯及其制备、处理和检测方法 |
US11591361B2 (en) * | 2020-12-29 | 2023-02-28 | Microsoft Technology Licensing, Llc | Linker structures with minimal scar for enzymatic synthesis |
CN115197291A (zh) * | 2021-04-01 | 2022-10-18 | 深圳华大生命科学研究院 | 用于测序的核苷酸类似物 |
Citations (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772691A (en) * | 1985-06-05 | 1988-09-20 | The Medical College Of Wisconsin, Inc. | Chemically cleavable nucleotides |
US4824775A (en) * | 1985-01-03 | 1989-04-25 | Molecular Diagnostics, Inc. | Cells labeled with multiple Fluorophores bound to a nucleic acid carrier |
US4863849A (en) * | 1985-07-18 | 1989-09-05 | New York Medical College | Automatable process for sequencing nucleotide |
US5043272A (en) * | 1989-04-27 | 1991-08-27 | Life Technologies, Incorporated | Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers |
US5118605A (en) * | 1984-10-16 | 1992-06-02 | Chiron Corporation | Polynucleotide determination with selectable cleavage sites |
US5308990A (en) * | 1991-05-15 | 1994-05-03 | Hitachi, Ltd. | Method for measuring microparticles, quantitative measuring method therefor and instrument for measuring microparticles |
US5328824A (en) * | 1981-04-17 | 1994-07-12 | Yale University | Methods of using labeled nucleotides |
US5332666A (en) * | 1986-07-02 | 1994-07-26 | E. I. Du Pont De Nemours And Company | Method, system and reagents for DNA sequencing |
US5436143A (en) * | 1992-12-23 | 1995-07-25 | Hyman; Edward D. | Method for enzymatic synthesis of oligonucleotides |
US5437975A (en) * | 1991-02-25 | 1995-08-01 | California Institute Of Biological Research | Consensus sequence primed polymerase chain reaction method for fingerprinting genomes |
US5516664A (en) * | 1992-12-23 | 1996-05-14 | Hyman; Edward D. | Enzymatic synthesis of repeat regions of oligonucleotides |
US5534424A (en) * | 1992-05-12 | 1996-07-09 | Cemu Bioteknik Ab | Chemical method for the analysis of DNA sequences |
US5547859A (en) * | 1993-08-02 | 1996-08-20 | Goodman; Myron F. | Chain-terminating nucleotides for DNA sequencing methods |
US5547839A (en) * | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5556748A (en) * | 1991-07-30 | 1996-09-17 | Xenopore Corporation | Methods of sandwich hybridization for the quantitative analysis of oligonucleotides |
US5599675A (en) * | 1994-04-04 | 1997-02-04 | Spectragen, Inc. | DNA sequencing by stepwise ligation and cleavage |
US5637469A (en) * | 1992-05-01 | 1997-06-10 | Trustees Of The University Of Pennsylvania | Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems |
US5654419A (en) * | 1994-02-01 | 1997-08-05 | The Regents Of The University Of California | Fluorescent labels and their use in separations |
US5658736A (en) * | 1996-01-16 | 1997-08-19 | Genetics Institute, Inc. | Oligonucleotide population preparation |
US5709999A (en) * | 1994-08-12 | 1998-01-20 | Myriad Genetics Inc. | Linked breast and ovarian cancer susceptibility gene |
US5728528A (en) * | 1995-09-20 | 1998-03-17 | The Regents Of The University Of California | Universal spacer/energy transfer dyes |
US5763594A (en) * | 1994-09-02 | 1998-06-09 | Andrew C. Hiatt | 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds |
US5770365A (en) * | 1995-08-25 | 1998-06-23 | Tm Technologies, Inc. | Nucleic acid capture moieties |
US5770367A (en) * | 1993-07-30 | 1998-06-23 | Oxford Gene Technology Limited | Tag reagent and assay method |
US5789167A (en) * | 1993-09-10 | 1998-08-04 | Genevue, Inc. | Optical detection of position of oligonucleotides on large DNA molecules |
US5798210A (en) * | 1993-03-26 | 1998-08-25 | Institut Pasteur | Derivatives utilizable in nucleic acid sequencing |
US5808045A (en) * | 1994-09-02 | 1998-09-15 | Andrew C. Hiatt | Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
US5821356A (en) * | 1996-08-12 | 1998-10-13 | The Perkin Elmer Corporation | Propargylethoxyamino nucleotides |
US5834203A (en) * | 1997-08-25 | 1998-11-10 | Applied Spectral Imaging | Method for classification of pixels into groups according to their spectra using a plurality of wide band filters and hardwire therefore |
US5856104A (en) * | 1996-10-28 | 1999-01-05 | Affymetrix, Inc. | Polymorphisms in the glucose-6 phosphate dehydrogenase locus |
US5869255A (en) * | 1994-02-01 | 1999-02-09 | The Regents Of The University Of California | Probes labeled with energy transfer couples dyes exemplified with DNA fragment analysis |
US5872244A (en) * | 1994-09-02 | 1999-02-16 | Andrew C. Hiatt | 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds |
US5885775A (en) * | 1996-10-04 | 1999-03-23 | Perseptive Biosystems, Inc. | Methods for determining sequences information in polynucleotides using mass spectrometry |
US5908755A (en) * | 1996-06-14 | 1999-06-01 | Sarnoff Corporation | Sequential step method for sequencing and identifying polynucleotides |
US5945283A (en) * | 1995-12-18 | 1999-08-31 | Washington University | Methods and kits for nucleic acid analysis using fluorescence resonance energy transfer |
US5962228A (en) * | 1995-11-17 | 1999-10-05 | Lynx Therapeutics, Inc. | DNA extension and analysis with rolling primers |
US6028190A (en) * | 1994-02-01 | 2000-02-22 | The Regents Of The University Of California | Probes labeled with energy transfer coupled dyes |
US6074823A (en) * | 1993-03-19 | 2000-06-13 | Sequenom, Inc. | DNA sequencing by mass spectrometry via exonuclease degradation |
US6087095A (en) * | 1992-04-22 | 2000-07-11 | Medical Research Council | DNA sequencing method |
US6136543A (en) * | 1997-01-31 | 2000-10-24 | Hitachi, Ltd. | Method for determining nucleic acids base sequence and apparatus therefor |
US6175107B1 (en) * | 1998-05-27 | 2001-01-16 | Owens-Brockway Glass Container Inc. | Inspection of containers employing a single area array sensor and alternately strobed light sources |
US6197557B1 (en) * | 1997-03-05 | 2001-03-06 | The Regents Of The University Of Michigan | Compositions and methods for analysis of nucleic acids |
US6210891B1 (en) * | 1996-09-27 | 2001-04-03 | Pyrosequencing Ab | Method of sequencing DNA |
US6214987B1 (en) * | 1994-09-02 | 2001-04-10 | Andrew C. Hiatt | Compositions for enzyme catalyzed template-independent formation of phosphodiester bonds using protected nucleotides |
US6218530B1 (en) * | 1998-06-02 | 2001-04-17 | Ambergen Inc. | Compounds and methods for detecting biomolecules |
US6218118B1 (en) * | 1998-07-09 | 2001-04-17 | Agilent Technologies, Inc. | Method and mixture reagents for analyzing the nucleotide sequence of nucleic acids by mass spectrometry |
US6221592B1 (en) * | 1998-10-20 | 2001-04-24 | Wisconsin Alumi Research Foundation | Computer-based methods and systems for sequencing of individual nucleic acid molecules |
US6232465B1 (en) * | 1994-09-02 | 2001-05-15 | Andrew C. Hiatt | Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
US6242193B1 (en) * | 1999-07-30 | 2001-06-05 | Hitachi, Ltd. | Apparatus for determining base sequence of nucleic acid |
US6245507B1 (en) * | 1998-08-18 | 2001-06-12 | Orchid Biosciences, Inc. | In-line complete hyperspectral fluorescent imaging of nucleic acid molecules |
US6255475B1 (en) * | 1995-01-31 | 2001-07-03 | Marek Kwiatkowski | Chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation |
US6274320B1 (en) * | 1999-09-16 | 2001-08-14 | Curagen Corporation | Method of sequencing a nucleic acid |
US6277607B1 (en) * | 1999-05-24 | 2001-08-21 | Sanjay Tyagi | High specificity primers, amplification methods and kits |
US6287821B1 (en) * | 1998-06-11 | 2001-09-11 | Orchid Biosciences, Inc. | Nucleotide analogues with 3'-pro-fluorescent fluorophores in nucleic acid sequence analysis |
US6294324B1 (en) * | 1994-02-11 | 2001-09-25 | Institut Pasteur | Processing for attaching an end of a nucleic acid to a surface by utilizing pH |
US6309836B1 (en) * | 1999-10-05 | 2001-10-30 | Marek Kwiatkowski | Compounds for protecting hydroxyls and methods for their use |
US20020012966A1 (en) * | 1999-08-16 | 2002-01-31 | Yanggu Shi | 18 Human secreted proteins |
US6361940B1 (en) * | 1996-09-24 | 2002-03-26 | Qiagen Genomics, Inc. | Compositions and methods for enhancing hybridization and priming specificity |
US6380378B1 (en) * | 1998-12-24 | 2002-04-30 | Toagosei Company, Ltd. | Nucleotide compound, nucleotide block oligonucleotide, and method for producing them |
US20030008285A1 (en) * | 2001-06-29 | 2003-01-09 | Fischer Steven M. | Method of DNA sequencing using cleavable tags |
US20030022225A1 (en) * | 1996-12-10 | 2003-01-30 | Monforte Joseph A. | Releasable nonvolatile mass-label molecules |
US6524829B1 (en) * | 1998-09-30 | 2003-02-25 | Molecular Machines & Industries Gmbh | Method for DNA- or RNA-sequencing |
US20030044871A1 (en) * | 2001-08-27 | 2003-03-06 | Pharmanetics Incorporated | Coagulation assay reagents containing lanthanides and a protein C assay using such a lanthanide-containing reagent |
US20030054360A1 (en) * | 1999-01-19 | 2003-03-20 | Larry Gold | Method and apparatus for the automated generation of nucleic acid ligands |
US6555349B1 (en) * | 1993-01-22 | 2003-04-29 | Cornell Research Foundation, Inc. | Methods for amplifying and sequencing nucleic acid molecules using a three component polymerase |
US20030099972A1 (en) * | 2001-07-13 | 2003-05-29 | Ambergen, Inc. | Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
US6613508B1 (en) * | 1996-01-23 | 2003-09-02 | Qiagen Genomics, Inc. | Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
US20030166282A1 (en) * | 2002-02-01 | 2003-09-04 | David Brown | High potency siRNAS for reducing the expression of target genes |
US20030186256A1 (en) * | 1999-12-23 | 2003-10-02 | Achim Fischer | Method for carrying out the parallel sequencing of a nucleic acid mixture on a surface |
US20030190680A1 (en) * | 1994-05-11 | 2003-10-09 | The Trustees Of Boston University | Photocleavable bioreactive agents |
US20030198982A1 (en) * | 2000-08-03 | 2003-10-23 | Frank Seela | Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
US20040014096A1 (en) * | 2002-04-12 | 2004-01-22 | Stratagene | Dual-labeled nucleotides |
US6713255B1 (en) * | 1999-06-07 | 2004-03-30 | Fuji Photo Film Co., Ltd. | DNA chip, PNA chip, and their preparation methods |
US20040096825A1 (en) * | 1999-04-30 | 2004-05-20 | Aclara Biosciences, Inc. | Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents |
US6780591B2 (en) * | 1998-05-01 | 2004-08-24 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US6787308B2 (en) * | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
US20040185466A1 (en) * | 2000-10-06 | 2004-09-23 | The Trustees Of Columbia University In The City Of New York. | Massive parallel method for decoding DNA and RNA |
US6864052B1 (en) * | 1999-01-06 | 2005-03-08 | Callida Genomics, Inc. | Enhanced sequencing by hybridization using pools of probes |
US6911345B2 (en) * | 1999-06-28 | 2005-06-28 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
US20050170367A1 (en) * | 2003-06-10 | 2005-08-04 | Quake Stephen R. | Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids |
US6934636B1 (en) * | 1999-10-22 | 2005-08-23 | Genset, S.A. | Methods of genetic cluster analysis and uses thereof |
US20050239134A1 (en) * | 2004-04-21 | 2005-10-27 | Board Of Regents, The University Of Texas System | Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein |
US6982146B1 (en) * | 1999-08-30 | 2006-01-03 | The United States Of America As Represented By The Department Of Health And Human Services | High speed parallel molecular nucleic acid sequencing |
US7037687B2 (en) * | 1998-05-01 | 2006-05-02 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US20060105461A1 (en) * | 2004-10-22 | 2006-05-18 | May Tom-Moy | Nanopore analysis system |
US7056661B2 (en) * | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
US7078499B2 (en) * | 2000-06-01 | 2006-07-18 | Ge Healthcare Uk Limited | Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety |
US20060160081A1 (en) * | 2002-08-23 | 2006-07-20 | John Milton | Labelled nucleotides |
US7105300B2 (en) * | 1999-02-23 | 2006-09-12 | Caliper Life Sciences, Inc. | Sequencing by incorporation |
US20060240439A1 (en) * | 2003-09-11 | 2006-10-26 | Smith Geoffrey P | Modified polymerases for improved incorporation of nucleotide analogues |
US20070166705A1 (en) * | 2002-08-23 | 2007-07-19 | John Milton | Modified nucleotides |
US7427673B2 (en) * | 2001-12-04 | 2008-09-23 | Illumina Cambridge Limited | Labelled nucleotides |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175269A (en) | 1984-01-30 | 1992-12-29 | Enzo Diagnostics, Inc. | Compound and detectable molecules having an oligo- or polynucleotide with modifiable reactive group |
US4888274A (en) | 1985-09-18 | 1989-12-19 | Yale University | RecA nucleoprotein filament and methods |
SE8801070D0 (sv) | 1988-03-23 | 1988-03-23 | Pharmacia Ab | Method for immobilizing a dna sequence on a solid support |
US5174962A (en) | 1988-06-20 | 1992-12-29 | Genomyx, Inc. | Apparatus for determining DNA sequences by mass spectrometry |
GB8910880D0 (en) | 1989-05-11 | 1989-06-28 | Amersham Int Plc | Sequencing method |
US5302509A (en) | 1989-08-14 | 1994-04-12 | Beckman Instruments, Inc. | Method for sequencing polynucleotides |
WO1991006678A1 (en) | 1989-10-26 | 1991-05-16 | Sri International | Dna sequencing |
AU2674092A (en) | 1991-09-09 | 1993-04-05 | Baylor College Of Medicine | Method and device for rapid dna or rna sequencing determination by a base addition sequencing scheme |
DE4141178A1 (de) | 1991-12-13 | 1993-06-17 | Europ Lab Molekularbiolog | Verfahren zur sequenzierung von nukleinsaeuren |
DE4141698A1 (de) | 1991-12-18 | 1993-07-01 | Bosch Gmbh Robert | Verfahren zur schliesszeitregelung |
US5959089A (en) | 1993-07-19 | 1999-09-28 | Hannessian; Stephen | Amino-cyclodextrin syntheses |
EP0765401B1 (en) | 1993-11-17 | 2001-02-21 | Amersham Pharmacia Biotech UK Limited | Primer extension mass spectroscopy nucleic acid sequencing method |
US20020168642A1 (en) | 1994-06-06 | 2002-11-14 | Andrzej Drukier | Sequencing duplex DNA by mass spectroscopy |
US6013445A (en) | 1996-06-06 | 2000-01-11 | Lynx Therapeutics, Inc. | Massively parallel signature sequencing by ligation of encoded adaptors |
WO1996027025A1 (en) | 1995-02-27 | 1996-09-06 | Ely Michael Rabani | Device, compounds, algorithms, and methods of molecular characterization and manipulation with molecular parallelism |
EP0745686A1 (en) | 1995-06-01 | 1996-12-04 | Roche Diagnostics GmbH | The use of DNA polymerase 3'-intrinsic editing activity |
EP0992511B1 (en) | 1996-01-23 | 2009-03-11 | Operon Biotechnologies, Inc. | Methods and compositions for determining the sequence of nucleic acid molecules |
JP2002515738A (ja) | 1996-01-23 | 2002-05-28 | アフィメトリックス,インコーポレイティド | 核酸分析法 |
US6312893B1 (en) | 1996-01-23 | 2001-11-06 | Qiagen Genomics, Inc. | Methods and compositions for determining the sequence of nucleic acid molecules |
AU2320597A (en) | 1996-03-19 | 1997-10-10 | Molecular Tool, Inc. | Method for determining the nucleotide sequence of a polynucleotide |
US5853992A (en) | 1996-10-04 | 1998-12-29 | The Regents Of The University Of California | Cyanine dyes with high-absorbance cross section as donor chromophores in energy transfer labels |
EP1015629A1 (en) | 1997-01-08 | 2000-07-05 | Proligo L.L.C. | Bioconjugation of oligonucleotides |
US5876936A (en) | 1997-01-15 | 1999-03-02 | Incyte Pharmaceuticals, Inc. | Nucleic acid sequencing with solid phase capturable terminators |
US5804386A (en) | 1997-01-15 | 1998-09-08 | Incyte Pharmaceuticals, Inc. | Sets of labeled energy transfer fluorescent primers and their use in multi component analysis |
US6046005A (en) | 1997-01-15 | 2000-04-04 | Incyte Pharmaceuticals, Inc. | Nucleic acid sequencing with solid phase capturable terminators comprising a cleavable linking group |
EP0866071B1 (en) | 1997-03-20 | 2004-10-20 | F. Hoffmann-La Roche Ag | Modified primers |
EP3034626A1 (en) | 1997-04-01 | 2016-06-22 | Illumina Cambridge Limited | Method of nucleic acid sequencing |
US6309829B1 (en) | 1997-05-27 | 2001-10-30 | Pe Corporation (Ny) | Length determination of nucleic acid repeat sequences by discontinuous primer extension |
PT1017848E (pt) | 1997-07-28 | 2003-02-28 | Medical Biosystems Ltd | Analise de sequencias de acido nucleico |
US6008379A (en) | 1997-10-01 | 1999-12-28 | The Perkin-Elmer Corporation | Aromatic-substituted xanthene dyes |
US6511803B1 (en) | 1997-10-10 | 2003-01-28 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
GB9815163D0 (en) | 1998-07-13 | 1998-09-09 | Brax Genomics Ltd | Compounds |
US6096875A (en) | 1998-05-29 | 2000-08-01 | The Perlein-Elmer Corporation | Nucleotide compounds including a rigid linker |
US6335155B1 (en) * | 1998-06-26 | 2002-01-01 | Sunesis Pharmaceuticals, Inc. | Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules |
CA2339121A1 (en) | 1998-07-30 | 2000-02-10 | Shankar Balasubramanian | Arrayed biomolecules and their use in sequencing |
GB0002310D0 (en) | 2000-02-01 | 2000-03-22 | Solexa Ltd | Polynucleotide sequencing |
WO2000009753A1 (en) | 1998-08-11 | 2000-02-24 | Caliper Technologies Corp. | Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes |
US20020012913A1 (en) | 1998-09-15 | 2002-01-31 | Kevin L. Gunderson | Nucleic acid analysis using complete n-mer arrays |
US6500650B1 (en) | 1998-10-01 | 2002-12-31 | Variagenics, Inc. | Method for identifying polymorphisms |
US6207831B1 (en) | 1998-12-21 | 2001-03-27 | Novartis Ag | Fluorescent dyes (AIDA) for solid phase and solution phase screening |
AU3174600A (en) | 1999-03-10 | 2000-09-28 | Asm Scientific, Inc. | A method for direct nucleic acid sequencing |
US6316230B1 (en) | 1999-08-13 | 2001-11-13 | Applera Corporation | Polymerase extension at 3′ terminus of PNA-DNA chimera |
AU7086800A (en) | 1999-08-30 | 2001-03-26 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | High speed parallel molecular nucleic acid sequencing |
US6664399B1 (en) | 1999-09-02 | 2003-12-16 | E. I. Du Pont De Nemours & Company | Triazole linked carbohydrates |
WO2001023610A2 (en) | 1999-09-29 | 2001-04-05 | Solexa Ltd. | Polynucleotide sequencing |
US8048659B1 (en) | 1999-10-08 | 2011-11-01 | Leif Robert C | Conjugated polymer tag complexes |
EP1228244A4 (en) | 1999-11-04 | 2005-02-09 | California Inst Of Techn | METHODS AND DEVICES FOR ANALYZING POLYNUCLEOTIDE SEQUENCES |
GB0002389D0 (en) | 2000-02-02 | 2000-03-22 | Solexa Ltd | Molecular arrays |
WO2001073121A1 (fr) | 2000-03-30 | 2001-10-04 | Toyota Jidosha Kabushiki Kaisha | Procede pour determiner une sequence de base d'une molecule individuelle d'acide nucleique |
GB0016473D0 (en) | 2000-07-05 | 2000-08-23 | Amersham Pharm Biotech Uk Ltd | Sequencing method |
US20060057565A1 (en) | 2000-09-11 | 2006-03-16 | Jingyue Ju | Combinatorial fluorescence energy transfer tags and uses thereof |
US6627748B1 (en) | 2000-09-11 | 2003-09-30 | The Trustees Of Columbia University In The City Of New York | Combinatorial fluorescence energy transfer tags and their applications for multiplex genetic analyses |
AU8911101A (en) | 2000-09-11 | 2002-03-26 | Univ Columbia | Combinatorial fluorescence energy transfer tags and uses thereof |
WO2002072892A1 (en) | 2001-03-12 | 2002-09-19 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
US20030027140A1 (en) | 2001-03-30 | 2003-02-06 | Jingyue Ju | High-fidelity DNA sequencing using solid phase capturable dideoxynucleotides and mass spectrometry |
DE10120798B4 (de) | 2001-04-27 | 2005-12-29 | Genovoxx Gmbh | Verfahren zur Bestimmung der Genexpression |
DE10120797B4 (de) | 2001-04-27 | 2005-12-22 | Genovoxx Gmbh | Verfahren zur Analyse von Nukleinsäureketten |
AU2002337030A1 (en) | 2001-08-29 | 2003-03-18 | Genovoxx Gmbh | Method for analyzing nucleic acid sequences and gene expression |
GB0128526D0 (en) | 2001-11-29 | 2002-01-23 | Amersham Pharm Biotech Uk Ltd | Nucleotide analogues |
AU2003244370A1 (en) | 2002-02-05 | 2003-09-02 | Baylor College Of Medecine | Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing |
CA2481495C (en) | 2002-04-04 | 2011-08-30 | Biotage Ab | Primer extension based method employing nucleotides labelled via cleavable linkers |
US7074597B2 (en) | 2002-07-12 | 2006-07-11 | The Trustees Of Columbia University In The City Of New York | Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry |
ES2694651T3 (es) * | 2002-08-23 | 2018-12-26 | Illumina Cambridge Limited | Nucleótidos etiquetados |
AU2003297859A1 (en) | 2002-12-13 | 2004-07-09 | The Trustees Of Columbia University In The City Of New York | Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry |
EP2436778A3 (en) | 2004-03-03 | 2012-07-11 | The Trustees of Columbia University in the City of New York | Photocleavable fluorescent nucleotides for DNA sequencing on chip constructed by site-specific coupling chemistry |
WO2006073436A2 (en) | 2004-04-29 | 2006-07-13 | The Trustees Of Columbia University In The City Of New York | Mass tag pcr for multiplex diagnostics |
WO2006097320A2 (de) | 2005-03-17 | 2006-09-21 | Genovoxx Gmbh | Makromolekulare nukleotidverbindungen und methoden zu deren anwendung |
US7393533B1 (en) | 2004-11-08 | 2008-07-01 | La Jolla Institute For Allergy And Immunology | H3L envelope protein immunization methods and H3L envelope passive protection methods |
WO2007002204A2 (en) | 2005-06-21 | 2007-01-04 | The Trustees Of Columbia University In The City Of New York | Pyrosequencing methods and related compostions |
GB0517097D0 (en) * | 2005-08-19 | 2005-09-28 | Solexa Ltd | Modified nucleosides and nucleotides and uses thereof |
GB2446084B (en) | 2005-10-31 | 2011-03-02 | Univ Columbia | Synthesis of four color 3-o-allyl modified photocleavable fluorescent nucleotides and related methods |
US8796432B2 (en) | 2005-10-31 | 2014-08-05 | The Trustees Of Columbia University In The City Of New York | Chemically cleavable 3'-o-allyl-DNTP-allyl-fluorophore fluorescent nucleotide analogues and related methods |
US20090088332A1 (en) | 2005-11-21 | 2009-04-02 | Jingyue Ju | Multiplex Digital Immuno-Sensing Using a Library of Photocleavable Mass Tags |
EP2021415B1 (en) * | 2006-05-18 | 2017-03-15 | Illumina Cambridge Limited | Dye compounds and the use of their labelled conjugates |
US8889348B2 (en) | 2006-06-07 | 2014-11-18 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by nanopore using modified nucleotides |
WO2008069973A2 (en) | 2006-12-01 | 2008-06-12 | The Trustees Of Columbia University In The City Of New York | Four-color dna sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators |
US8612161B2 (en) | 2008-03-19 | 2013-12-17 | Intelligent Biosystems Inc. | Methods and compositions for base calling nucleic acids |
US8481259B2 (en) | 2007-02-05 | 2013-07-09 | Intelligent Bio-Systems, Inc. | Methods and devices for sequencing nucleic acids in smaller batches |
US9115163B2 (en) | 2007-10-19 | 2015-08-25 | The Trustees Of Columbia University In The City Of New York | DNA sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators |
US20110014611A1 (en) | 2007-10-19 | 2011-01-20 | Jingyue Ju | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis |
US9309569B2 (en) | 2010-08-26 | 2016-04-12 | Intelligent Bio-Systems, Inc. | Methods and compositions for sequencing nucleic acid using charge |
CN107083421A (zh) | 2010-12-17 | 2017-08-22 | 纽约哥伦比亚大学理事会 | 使用经修饰的核苷酸和纳米孔检测的dna边合成边测序 |
EP2836604B1 (en) | 2012-04-09 | 2021-09-15 | The Trustees of Columbia University in the City of New York | Method of preparation of nanopore and uses thereof |
WO2013191793A1 (en) | 2012-06-20 | 2013-12-27 | The Trustees Of Columbia University In The City Of New York | Nucleic acid sequencing by nanopore detection of tag molecules |
WO2014144883A1 (en) | 2013-03-15 | 2014-09-18 | The Trustees Of Columbia University In The City Of New York | Raman cluster tagged molecules for biological imaging |
EP2971051A4 (en) | 2013-03-15 | 2017-03-01 | The Trustees of Columbia University in the City of New York | Method for detecting multiple predetermined compounds in a sample |
-
2008
- 2008-10-17 US US12/734,227 patent/US20110014611A1/en not_active Abandoned
- 2008-10-17 EP EP23212547.6A patent/EP4310194A2/en active Pending
- 2008-10-17 WO PCT/US2008/011891 patent/WO2009051807A1/en active Application Filing
- 2008-10-17 EP EP15165262.5A patent/EP2940029B1/en active Active
- 2008-10-17 EP EP20080839081 patent/EP2207900B1/en active Active
-
2013
- 2013-07-25 US US13/951,269 patent/US9175342B2/en active Active
-
2015
- 2015-09-21 US US14/859,853 patent/US9670539B2/en active Active
-
2016
- 2016-05-04 HK HK16105093.7A patent/HK1217106A1/zh unknown
-
2017
- 2017-05-16 US US15/596,379 patent/US10144961B2/en active Active
-
2018
- 2018-12-03 US US16/208,379 patent/US11208691B2/en active Active
-
2021
- 2021-12-23 US US17/560,928 patent/US20220112552A1/en active Pending
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449767A (en) * | 1981-04-17 | 1995-09-12 | Yale University | Modified polynucleotides and methods of preparing same |
US5328824A (en) * | 1981-04-17 | 1994-07-12 | Yale University | Methods of using labeled nucleotides |
US5118605A (en) * | 1984-10-16 | 1992-06-02 | Chiron Corporation | Polynucleotide determination with selectable cleavage sites |
US4824775A (en) * | 1985-01-03 | 1989-04-25 | Molecular Diagnostics, Inc. | Cells labeled with multiple Fluorophores bound to a nucleic acid carrier |
US4772691A (en) * | 1985-06-05 | 1988-09-20 | The Medical College Of Wisconsin, Inc. | Chemically cleavable nucleotides |
US4863849A (en) * | 1985-07-18 | 1989-09-05 | New York Medical College | Automatable process for sequencing nucleotide |
US5332666A (en) * | 1986-07-02 | 1994-07-26 | E. I. Du Pont De Nemours And Company | Method, system and reagents for DNA sequencing |
US5043272A (en) * | 1989-04-27 | 1991-08-27 | Life Technologies, Incorporated | Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers |
US5547839A (en) * | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US7056666B2 (en) * | 1990-12-06 | 2006-06-06 | Affymetrix, Inc. | Analysis of surface immobilized polymers utilizing microfluorescence detection |
US7329496B2 (en) * | 1990-12-06 | 2008-02-12 | Affymetrix, Inc. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5437975A (en) * | 1991-02-25 | 1995-08-01 | California Institute Of Biological Research | Consensus sequence primed polymerase chain reaction method for fingerprinting genomes |
US5308990A (en) * | 1991-05-15 | 1994-05-03 | Hitachi, Ltd. | Method for measuring microparticles, quantitative measuring method therefor and instrument for measuring microparticles |
US5556748A (en) * | 1991-07-30 | 1996-09-17 | Xenopore Corporation | Methods of sandwich hybridization for the quantitative analysis of oligonucleotides |
US6087095A (en) * | 1992-04-22 | 2000-07-11 | Medical Research Council | DNA sequencing method |
US5637469A (en) * | 1992-05-01 | 1997-06-10 | Trustees Of The University Of Pennsylvania | Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems |
US5534424A (en) * | 1992-05-12 | 1996-07-09 | Cemu Bioteknik Ab | Chemical method for the analysis of DNA sequences |
US5602000A (en) * | 1992-12-23 | 1997-02-11 | Hyman; Edward D. | Method for enzymatic synthesis of oligonucleotides |
US5436143A (en) * | 1992-12-23 | 1995-07-25 | Hyman; Edward D. | Method for enzymatic synthesis of oligonucleotides |
US5516664A (en) * | 1992-12-23 | 1996-05-14 | Hyman; Edward D. | Enzymatic synthesis of repeat regions of oligonucleotides |
US6555349B1 (en) * | 1993-01-22 | 2003-04-29 | Cornell Research Foundation, Inc. | Methods for amplifying and sequencing nucleic acid molecules using a three component polymerase |
US6074823A (en) * | 1993-03-19 | 2000-06-13 | Sequenom, Inc. | DNA sequencing by mass spectrometry via exonuclease degradation |
US5798210A (en) * | 1993-03-26 | 1998-08-25 | Institut Pasteur | Derivatives utilizable in nucleic acid sequencing |
US5770367A (en) * | 1993-07-30 | 1998-06-23 | Oxford Gene Technology Limited | Tag reagent and assay method |
US5547859A (en) * | 1993-08-02 | 1996-08-20 | Goodman; Myron F. | Chain-terminating nucleotides for DNA sequencing methods |
US5789167A (en) * | 1993-09-10 | 1998-08-04 | Genevue, Inc. | Optical detection of position of oligonucleotides on large DNA molecules |
US5869255A (en) * | 1994-02-01 | 1999-02-09 | The Regents Of The University Of California | Probes labeled with energy transfer couples dyes exemplified with DNA fragment analysis |
US6028190A (en) * | 1994-02-01 | 2000-02-22 | The Regents Of The University Of California | Probes labeled with energy transfer coupled dyes |
US5654419A (en) * | 1994-02-01 | 1997-08-05 | The Regents Of The University Of California | Fluorescent labels and their use in separations |
US6294324B1 (en) * | 1994-02-11 | 2001-09-25 | Institut Pasteur | Processing for attaching an end of a nucleic acid to a surface by utilizing pH |
US5599675A (en) * | 1994-04-04 | 1997-02-04 | Spectragen, Inc. | DNA sequencing by stepwise ligation and cleavage |
US20030190680A1 (en) * | 1994-05-11 | 2003-10-09 | The Trustees Of Boston University | Photocleavable bioreactive agents |
US5709999A (en) * | 1994-08-12 | 1998-01-20 | Myriad Genetics Inc. | Linked breast and ovarian cancer susceptibility gene |
US5872244A (en) * | 1994-09-02 | 1999-02-16 | Andrew C. Hiatt | 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds |
US6232465B1 (en) * | 1994-09-02 | 2001-05-15 | Andrew C. Hiatt | Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
US6214987B1 (en) * | 1994-09-02 | 2001-04-10 | Andrew C. Hiatt | Compositions for enzyme catalyzed template-independent formation of phosphodiester bonds using protected nucleotides |
US5808045A (en) * | 1994-09-02 | 1998-09-15 | Andrew C. Hiatt | Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
US5763594A (en) * | 1994-09-02 | 1998-06-09 | Andrew C. Hiatt | 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds |
US6255475B1 (en) * | 1995-01-31 | 2001-07-03 | Marek Kwiatkowski | Chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation |
US5770365A (en) * | 1995-08-25 | 1998-06-23 | Tm Technologies, Inc. | Nucleic acid capture moieties |
US5728528A (en) * | 1995-09-20 | 1998-03-17 | The Regents Of The University Of California | Universal spacer/energy transfer dyes |
US5962228A (en) * | 1995-11-17 | 1999-10-05 | Lynx Therapeutics, Inc. | DNA extension and analysis with rolling primers |
US5945283A (en) * | 1995-12-18 | 1999-08-31 | Washington University | Methods and kits for nucleic acid analysis using fluorescence resonance energy transfer |
US5658736A (en) * | 1996-01-16 | 1997-08-19 | Genetics Institute, Inc. | Oligonucleotide population preparation |
US6613508B1 (en) * | 1996-01-23 | 2003-09-02 | Qiagen Genomics, Inc. | Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
US5908755A (en) * | 1996-06-14 | 1999-06-01 | Sarnoff Corporation | Sequential step method for sequencing and identifying polynucleotides |
US5821356A (en) * | 1996-08-12 | 1998-10-13 | The Perkin Elmer Corporation | Propargylethoxyamino nucleotides |
US6361940B1 (en) * | 1996-09-24 | 2002-03-26 | Qiagen Genomics, Inc. | Compositions and methods for enhancing hybridization and priming specificity |
US6210891B1 (en) * | 1996-09-27 | 2001-04-03 | Pyrosequencing Ab | Method of sequencing DNA |
US5885775A (en) * | 1996-10-04 | 1999-03-23 | Perseptive Biosystems, Inc. | Methods for determining sequences information in polynucleotides using mass spectrometry |
US5856104A (en) * | 1996-10-28 | 1999-01-05 | Affymetrix, Inc. | Polymorphisms in the glucose-6 phosphate dehydrogenase locus |
US20030022225A1 (en) * | 1996-12-10 | 2003-01-30 | Monforte Joseph A. | Releasable nonvolatile mass-label molecules |
US6136543A (en) * | 1997-01-31 | 2000-10-24 | Hitachi, Ltd. | Method for determining nucleic acids base sequence and apparatus therefor |
US6197557B1 (en) * | 1997-03-05 | 2001-03-06 | The Regents Of The University Of Michigan | Compositions and methods for analysis of nucleic acids |
US5834203A (en) * | 1997-08-25 | 1998-11-10 | Applied Spectral Imaging | Method for classification of pixels into groups according to their spectra using a plurality of wide band filters and hardwire therefore |
US7037687B2 (en) * | 1998-05-01 | 2006-05-02 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US6780591B2 (en) * | 1998-05-01 | 2004-08-24 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US6175107B1 (en) * | 1998-05-27 | 2001-01-16 | Owens-Brockway Glass Container Inc. | Inspection of containers employing a single area array sensor and alternately strobed light sources |
US6218530B1 (en) * | 1998-06-02 | 2001-04-17 | Ambergen Inc. | Compounds and methods for detecting biomolecules |
US6287821B1 (en) * | 1998-06-11 | 2001-09-11 | Orchid Biosciences, Inc. | Nucleotide analogues with 3'-pro-fluorescent fluorophores in nucleic acid sequence analysis |
US6218118B1 (en) * | 1998-07-09 | 2001-04-17 | Agilent Technologies, Inc. | Method and mixture reagents for analyzing the nucleotide sequence of nucleic acids by mass spectrometry |
US6787308B2 (en) * | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
US6245507B1 (en) * | 1998-08-18 | 2001-06-12 | Orchid Biosciences, Inc. | In-line complete hyperspectral fluorescent imaging of nucleic acid molecules |
US6524829B1 (en) * | 1998-09-30 | 2003-02-25 | Molecular Machines & Industries Gmbh | Method for DNA- or RNA-sequencing |
US6221592B1 (en) * | 1998-10-20 | 2001-04-24 | Wisconsin Alumi Research Foundation | Computer-based methods and systems for sequencing of individual nucleic acid molecules |
US6380378B1 (en) * | 1998-12-24 | 2002-04-30 | Toagosei Company, Ltd. | Nucleotide compound, nucleotide block oligonucleotide, and method for producing them |
US6864052B1 (en) * | 1999-01-06 | 2005-03-08 | Callida Genomics, Inc. | Enhanced sequencing by hybridization using pools of probes |
US20030054360A1 (en) * | 1999-01-19 | 2003-03-20 | Larry Gold | Method and apparatus for the automated generation of nucleic acid ligands |
US7105300B2 (en) * | 1999-02-23 | 2006-09-12 | Caliper Life Sciences, Inc. | Sequencing by incorporation |
US20040096825A1 (en) * | 1999-04-30 | 2004-05-20 | Aclara Biosciences, Inc. | Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents |
US7056661B2 (en) * | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
US6277607B1 (en) * | 1999-05-24 | 2001-08-21 | Sanjay Tyagi | High specificity primers, amplification methods and kits |
US6713255B1 (en) * | 1999-06-07 | 2004-03-30 | Fuji Photo Film Co., Ltd. | DNA chip, PNA chip, and their preparation methods |
US6911345B2 (en) * | 1999-06-28 | 2005-06-28 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
US6242193B1 (en) * | 1999-07-30 | 2001-06-05 | Hitachi, Ltd. | Apparatus for determining base sequence of nucleic acid |
US20020012966A1 (en) * | 1999-08-16 | 2002-01-31 | Yanggu Shi | 18 Human secreted proteins |
US6982146B1 (en) * | 1999-08-30 | 2006-01-03 | The United States Of America As Represented By The Department Of Health And Human Services | High speed parallel molecular nucleic acid sequencing |
US6274320B1 (en) * | 1999-09-16 | 2001-08-14 | Curagen Corporation | Method of sequencing a nucleic acid |
US6639088B2 (en) * | 1999-10-05 | 2003-10-28 | Quiatech Ab | Compounds for protecting hydroxyls and methods for their use |
US6309836B1 (en) * | 1999-10-05 | 2001-10-30 | Marek Kwiatkowski | Compounds for protecting hydroxyls and methods for their use |
US6934636B1 (en) * | 1999-10-22 | 2005-08-23 | Genset, S.A. | Methods of genetic cluster analysis and uses thereof |
US20030186256A1 (en) * | 1999-12-23 | 2003-10-02 | Achim Fischer | Method for carrying out the parallel sequencing of a nucleic acid mixture on a surface |
US7078499B2 (en) * | 2000-06-01 | 2006-07-18 | Ge Healthcare Uk Limited | Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety |
US20030198982A1 (en) * | 2000-08-03 | 2003-10-23 | Frank Seela | Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
US20040185466A1 (en) * | 2000-10-06 | 2004-09-23 | The Trustees Of Columbia University In The City Of New York. | Massive parallel method for decoding DNA and RNA |
US20030008285A1 (en) * | 2001-06-29 | 2003-01-09 | Fischer Steven M. | Method of DNA sequencing using cleavable tags |
US20030099972A1 (en) * | 2001-07-13 | 2003-05-29 | Ambergen, Inc. | Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
US20030044871A1 (en) * | 2001-08-27 | 2003-03-06 | Pharmanetics Incorporated | Coagulation assay reagents containing lanthanides and a protein C assay using such a lanthanide-containing reagent |
US7566537B2 (en) * | 2001-12-04 | 2009-07-28 | Illumina Cambridge Limited | Labelled nucleotides |
US7427673B2 (en) * | 2001-12-04 | 2008-09-23 | Illumina Cambridge Limited | Labelled nucleotides |
US20030166282A1 (en) * | 2002-02-01 | 2003-09-04 | David Brown | High potency siRNAS for reducing the expression of target genes |
US20040014096A1 (en) * | 2002-04-12 | 2004-01-22 | Stratagene | Dual-labeled nucleotides |
US20060160081A1 (en) * | 2002-08-23 | 2006-07-20 | John Milton | Labelled nucleotides |
US20070166705A1 (en) * | 2002-08-23 | 2007-07-19 | John Milton | Modified nucleotides |
US7414116B2 (en) * | 2002-08-23 | 2008-08-19 | Illumina Cambridge Limited | Labelled nucleotides |
US20050170367A1 (en) * | 2003-06-10 | 2005-08-04 | Quake Stephen R. | Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids |
US20060240439A1 (en) * | 2003-09-11 | 2006-10-26 | Smith Geoffrey P | Modified polymerases for improved incorporation of nucleotide analogues |
US20050239134A1 (en) * | 2004-04-21 | 2005-10-27 | Board Of Regents, The University Of Texas System | Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein |
US20060105461A1 (en) * | 2004-10-22 | 2006-05-18 | May Tom-Moy | Nanopore analysis system |
Cited By (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10662472B2 (en) | 2000-10-06 | 2020-05-26 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US9719139B2 (en) | 2000-10-06 | 2017-08-01 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10577652B2 (en) | 2000-10-06 | 2020-03-03 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10570446B2 (en) | 2000-10-06 | 2020-02-25 | The Trustee Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10633700B2 (en) | 2000-10-06 | 2020-04-28 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10457984B2 (en) | 2000-10-06 | 2019-10-29 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US9718852B2 (en) | 2000-10-06 | 2017-08-01 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10435742B2 (en) | 2000-10-06 | 2019-10-08 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US9725480B2 (en) | 2000-10-06 | 2017-08-08 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10428380B2 (en) | 2000-10-06 | 2019-10-01 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10648028B2 (en) | 2000-10-06 | 2020-05-12 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US9133511B2 (en) | 2000-10-06 | 2015-09-15 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US9868985B2 (en) | 2000-10-06 | 2018-01-16 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10407459B2 (en) | 2000-10-06 | 2019-09-10 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10669582B2 (en) | 2000-10-06 | 2020-06-02 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10669577B2 (en) | 2000-10-06 | 2020-06-02 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US9708358B2 (en) | 2000-10-06 | 2017-07-18 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US10407458B2 (en) | 2000-10-06 | 2019-09-10 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US9909177B2 (en) | 2005-06-21 | 2018-03-06 | The Trustees Of Columbia University In The City Of New York | Pyrosequencing methods and related compositions |
US20090325154A1 (en) * | 2005-06-21 | 2009-12-31 | The Trustees Of Columbia University In The City Of New York | Pyrosequencing Methods and Related Compositions |
US9169510B2 (en) | 2005-06-21 | 2015-10-27 | The Trustees Of Columbia University In The City Of New York | Pyrosequencing methods and related compositions |
US9297042B2 (en) | 2005-10-31 | 2016-03-29 | The Trustees Of Columbia University In The City Of New York | Chemically cleavable 3′-O-allyl-dNTP-allyl-fluorophore fluorescent nucleotide analogues and related methods |
US9255292B2 (en) | 2005-10-31 | 2016-02-09 | The Trustees Of Columbia University In The City Of New York | Synthesis of four-color 3′-O-allyl modified photocleavable fluorescent nucleotides and related methods |
US8796432B2 (en) | 2005-10-31 | 2014-08-05 | The Trustees Of Columbia University In The City Of New York | Chemically cleavable 3'-o-allyl-DNTP-allyl-fluorophore fluorescent nucleotide analogues and related methods |
US20090263791A1 (en) * | 2005-10-31 | 2009-10-22 | Jingyue Ju | Chemically Cleavable 3'-O-Allyl-DNTP-Allyl-Fluorophore Fluorescent Nucleotide Analogues and Related Methods |
US20090298072A1 (en) * | 2006-06-07 | 2009-12-03 | The Trustees Of Columbia University In The City Of | DNA Sequencing by Nanopore Using Modified Nucleotides |
US8889348B2 (en) | 2006-06-07 | 2014-11-18 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by nanopore using modified nucleotides |
US11939631B2 (en) | 2006-12-01 | 2024-03-26 | The Trustees Of Columbia University In The City Of New York | Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators |
US11098353B2 (en) | 2006-12-01 | 2021-08-24 | The Trustees Of Columbia University In The City Of New York | Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators |
US9528151B2 (en) | 2006-12-01 | 2016-12-27 | The Trustees Of Columbia University In The City Of New York | Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators |
US9115163B2 (en) | 2007-10-19 | 2015-08-25 | The Trustees Of Columbia University In The City Of New York | DNA sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators |
US9670539B2 (en) | 2007-10-19 | 2017-06-06 | The Trustees Of Columbia University In The City Of New York | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US10260094B2 (en) | 2007-10-19 | 2019-04-16 | The Trustees Of Columbia University In The City Of New York | DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators |
US11208691B2 (en) | 2007-10-19 | 2021-12-28 | The Trustees Of Columbia University In The City Of New York | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US11242561B2 (en) | 2007-10-19 | 2022-02-08 | The Trustees Of Columbia University In The City Of New York | DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators |
US9175342B2 (en) | 2007-10-19 | 2015-11-03 | The Trustees Of Columbia University In The City Of New York | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US10144961B2 (en) | 2007-10-19 | 2018-12-04 | The Trustees Of Columbia University In The City Of New York | Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis |
US20110039259A1 (en) * | 2007-10-19 | 2011-02-17 | Jingyue Ju | Dna sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators |
US11499186B2 (en) | 2010-12-17 | 2022-11-15 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by synthesis using modified nucleotides and nanopore detection |
US10443096B2 (en) | 2010-12-17 | 2019-10-15 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by synthesis using modified nucleotides and nanopore detection |
US9121059B2 (en) | 2010-12-22 | 2015-09-01 | Genia Technologies, Inc. | Nanopore-based single molecule characterization |
US9617593B2 (en) | 2010-12-22 | 2017-04-11 | Genia Technologies, Inc. | Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps |
US10400278B2 (en) | 2010-12-22 | 2019-09-03 | Genia Technologies, Inc. | Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps |
US10920271B2 (en) | 2010-12-22 | 2021-02-16 | Roche Sequencing Solutions, Inc. | Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps |
US8845880B2 (en) | 2010-12-22 | 2014-09-30 | Genia Technologies, Inc. | Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps |
US9624539B2 (en) | 2011-05-23 | 2017-04-18 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by synthesis using Raman and infrared spectroscopy detection |
US10689412B2 (en) | 2011-05-23 | 2020-06-23 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by synthesis using Raman and infrared spectroscopy detection |
WO2012162429A3 (en) * | 2011-05-23 | 2014-05-08 | The Trustees Of Columbia University In The City Of New York | Dna sequencing by synthesis using raman and infrared spectroscopy detection |
WO2012162429A2 (en) * | 2011-05-23 | 2012-11-29 | The Trustees Of Columbia University In The City Of New York | Dna sequencing by synthesis using raman and infrared spectroscopy detection |
US11795191B2 (en) | 2012-04-09 | 2023-10-24 | The Trustees Of Columbia University In The City Of New York | Method of preparation of nanopore and uses thereof |
US10246479B2 (en) | 2012-04-09 | 2019-04-02 | The Trustees Of Columbia University In The City Of New York | Method of preparation of nanopore and uses thereof |
US9494554B2 (en) | 2012-06-15 | 2016-11-15 | Genia Technologies, Inc. | Chip set-up and high-accuracy nucleic acid sequencing |
US10822650B2 (en) | 2012-11-09 | 2020-11-03 | Roche Sequencing Solutions, Inc. | Nucleic acid sequencing using tags |
US11674174B2 (en) | 2012-11-09 | 2023-06-13 | The Trustees Of Columbia University In The City Of New York | Nucleic acid sequences using tags |
US10526647B2 (en) | 2012-11-09 | 2020-01-07 | The Trustees Of Columbia University In The City Of New York | Nucleic acid sequences using tags |
US9605309B2 (en) | 2012-11-09 | 2017-03-28 | Genia Technologies, Inc. | Nucleic acid sequencing using tags |
US9146248B2 (en) | 2013-03-14 | 2015-09-29 | Intelligent Bio-Systems, Inc. | Apparatus and methods for purging flow cells in nucleic acid sequencing instruments |
US10732183B2 (en) | 2013-03-15 | 2020-08-04 | The Trustees Of Columbia University In The City Of New York | Method for detecting multiple predetermined compounds in a sample |
US9591268B2 (en) | 2013-03-15 | 2017-03-07 | Qiagen Waltham, Inc. | Flow cell alignment methods and systems |
US10648026B2 (en) | 2013-03-15 | 2020-05-12 | The Trustees Of Columbia University In The City Of New York | Raman cluster tagged molecules for biological imaging |
US10249038B2 (en) | 2013-03-15 | 2019-04-02 | Qiagen Sciences, Llc | Flow cell alignment methods and systems |
US9322062B2 (en) | 2013-10-23 | 2016-04-26 | Genia Technologies, Inc. | Process for biosensor well formation |
US9567630B2 (en) | 2013-10-23 | 2017-02-14 | Genia Technologies, Inc. | Methods for forming lipid bilayers on biochips |
US10421995B2 (en) | 2013-10-23 | 2019-09-24 | Genia Technologies, Inc. | High speed molecular sensing with nanopores |
US11021745B2 (en) | 2013-10-23 | 2021-06-01 | Roche Sequencing Solutions, Inc. | Methods for forming lipid bilayers on biochips |
US10240195B2 (en) | 2014-03-24 | 2019-03-26 | The Trustees Of Columbia University In The City Of New York | Chemical methods for producing tagged nucleotides |
US11396677B2 (en) | 2014-03-24 | 2022-07-26 | The Trustees Of Columbia University In The City Of New York | Chemical methods for producing tagged nucleotides |
US10190162B2 (en) | 2014-10-23 | 2019-01-29 | Complete Genomics, Inc. | Signal confinement sequencing (SCS) and nucleotide analogues for signal confinement sequencing |
JP2018518947A (ja) * | 2015-07-30 | 2018-07-19 | イラミーナ インコーポレーテッド | ヌクレオチドのオルトゴナルな脱ブロッキング |
WO2017019278A1 (en) * | 2015-07-30 | 2017-02-02 | Illumina, Inc. | Orthogonal deblocking of nucleotides |
US11155864B2 (en) | 2015-07-30 | 2021-10-26 | Illumina, Inc. | Orthogonal deblocking of nucleotides |
CN114634976A (zh) * | 2015-07-30 | 2022-06-17 | 亿明达股份有限公司 | 核苷酸的正交去封闭 |
CN106434873A (zh) * | 2015-08-13 | 2017-02-22 | 生捷科技控股公司 | 使核酸分子同步化的方法 |
US10584378B2 (en) | 2015-08-13 | 2020-03-10 | Centrillion Technology Holdings Corporation | Methods for synchronizing nucleic acid molecules |
WO2017027783A1 (en) * | 2015-08-13 | 2017-02-16 | Centrillion Technology Holdings Corporation | Methods for synchronising nucleic acid molecules |
US11959137B2 (en) | 2015-09-28 | 2024-04-16 | The Trustees Of Columbia University In The City Of New York | Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis |
US11085076B2 (en) | 2015-09-28 | 2021-08-10 | The Trustees Of Columbia University In The City Of New York | Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis |
US11591647B2 (en) | 2017-03-06 | 2023-02-28 | Singular Genomics Systems, Inc. | Nucleic acid sequencing-by-synthesis (SBS) methods that combine SBS cycle steps |
US11773439B2 (en) | 2017-03-06 | 2023-10-03 | Singular Genomics Systems, Inc. | Nucleic acid sequencing-by-synthesis (SBS) methods that combine SBS cycle steps |
US11878993B2 (en) | 2018-10-25 | 2024-01-23 | Singular Genomics Systems, Inc. | Nucleotide analogues |
US11958877B2 (en) | 2018-10-25 | 2024-04-16 | Singular Genomics Systems, Inc. | Nucleotide analogues |
US10822653B1 (en) | 2019-01-08 | 2020-11-03 | Singular Genomics Systems, Inc. | Nucleotide cleavable linkers and uses thereof |
WO2020146397A1 (en) * | 2019-01-08 | 2020-07-16 | Singular Genomics Systems, Inc. | Nucleotide cleavable linkers and uses thereof |
WO2020159447A1 (en) * | 2019-01-31 | 2020-08-06 | Agency For Science, Technology And Research | Method of synthesizing single-stranded nucleotide sequence, blocked nucleoside triphosphates and related methods |
US11970735B2 (en) | 2020-01-07 | 2024-04-30 | Singular Genomics Systems, Inc. | Nucleotide cleavable linkers and uses thereof |
US11174281B1 (en) | 2020-04-24 | 2021-11-16 | Singular Genomics Systems, Inc. | Modified nucleotides and uses thereof |
US11946103B2 (en) | 2021-12-10 | 2024-04-02 | Singular Genomics Systems, Inc. | Cleavable disulfide linkers and uses thereof |
CN114958995A (zh) * | 2022-04-27 | 2022-08-30 | 深圳赛陆医疗科技有限公司 | 一种基因测序方法 |
Also Published As
Publication number | Publication date |
---|---|
US9175342B2 (en) | 2015-11-03 |
US11208691B2 (en) | 2021-12-28 |
US20170321267A1 (en) | 2017-11-09 |
EP2207900B1 (en) | 2015-04-29 |
US9670539B2 (en) | 2017-06-06 |
EP4310194A2 (en) | 2024-01-24 |
US20160090621A1 (en) | 2016-03-31 |
US20220112552A1 (en) | 2022-04-14 |
EP2940029B1 (en) | 2023-11-29 |
EP2940029A1 (en) | 2015-11-04 |
HK1217106A1 (zh) | 2016-12-23 |
US20140093869A1 (en) | 2014-04-03 |
WO2009051807A1 (en) | 2009-04-23 |
EP2207900A1 (en) | 2010-07-21 |
EP2207900A4 (en) | 2014-01-15 |
US20190085388A1 (en) | 2019-03-21 |
US10144961B2 (en) | 2018-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220112552A1 (en) | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis | |
US11242561B2 (en) | DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators | |
US11939631B2 (en) | Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators | |
US7622279B2 (en) | Photocleavable fluorescent nucleotides for DNA sequencing on chip constructed by site-specific coupling chemistry | |
US20070207482A1 (en) | Wobble sequencing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JU, JINGYUE;CAO, HUANYAN;LI, ZENGMIN;AND OTHERS;SIGNING DATES FROM 20090610 TO 20090612;REEL/FRAME:023212/0241 |
|
AS | Assignment |
Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF Free format text: CONFIRMATORY LICENSE;ASSIGNOR:COLUMBIA UNIV NEW YORK MORNINGSIDE;REEL/FRAME:023224/0344 Effective date: 20081215 |
|
AS | Assignment |
Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF Free format text: CONFIRMATORY LICENSE;ASSIGNOR:COLUMBIA UNIV NEW YORK MORNINGSIDE;REEL/FRAME:023567/0877 Effective date: 20081215 |
|
AS | Assignment |
Owner name: NEW YORK, TRUSTEES OF COLUMBIA UNIVERSITY IN THE C Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JU, JINGYUE;CAO, HUANYAN;LI, ZENGMIN;AND OTHERS;SIGNING DATES FROM 20100427 TO 20100721;REEL/FRAME:024976/0176 |
|
AS | Assignment |
Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF Free format text: CONFIRMATORY LICENSE;ASSIGNOR:COLUMBIA UNIV NEW YORK MORNINGSIDE;REEL/FRAME:025676/0823 Effective date: 20110121 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |
|
AS | Assignment |
Owner name: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR, MA Free format text: CONFIRMATORY LICENSE;ASSIGNOR:THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK;REEL/FRAME:042434/0001 Effective date: 20110121 |